Feeds:
Posts
Comments

Archive for the ‘BioTechnology – Venture Creation, Venture Capital’ Category


World Leaders to meet during Davos Agenda in a crucial year to rebuild trust

Reporter: Aviva Lev-Ari, PhD, RN

 

Davos Agenda

https://www.weforum.org/events/the-davos-agenda-2021

 

Adrian Monck, Managing Director, Public Engagement, public.affairs@weforum.org

日本語 | 中文 | عربي

World Leaders to Meet During Davos Agenda in a Crucial Year to Rebuild Trust

  • The Davos Agenda 2021 will convene under the theme: A Crucial Year to Rebuild Trust
  • The World Economic Forum will gather the world’s foremost leaders to address the economic, environmental, social and technological challenges following the COVID-19 pandemic 
  • More than 1,500 business, government and civil society leaders from over 70 countries will set the agenda for a critical year ahead and discuss how to catalyse impact in the rapidly advancing Fourth Industrial Revolution
  • The conclusions from the Davos Agenda week will feed into task forces working on global issues for the upcoming Special Annual Meeting in Singapore
  • For more information, please visit http://www.weforum.org; share on social media using the hashtag #DavosAgenda

Geneva, Switzerland, 18 January 2021 – The World Economic Forum Davos Agenda, taking place virtually on 25-29 January, will bring together the foremost leaders of the world to address the new global situation. Heads of state and government, chief executives and leaders from civil society will convene under the theme: A Crucial Year to Rebuild Trust.

The meeting will focus on creating impact, rebuilding trust and shaping the policies and partnerships needed in 2021.

“In the context of the COVID-19 pandemic, the need to reset priorities and the urgency to reform systems have been growing stronger around the world,” said Klaus Schwab, Founder and Executive Chairman of the World Economic Forum. “Rebuilding trust and increasing global cooperation are crucial to fostering innovative and bold solutions to stem the pandemic and drive a robust recovery. This unique meeting will be an opportunity for leaders to outline their vision and address the most important issues of our time, such as the need to accelerate job creation and to protect the environment.”

The COVID-19 pandemic has demonstrated that no institution or individual alone can address the economic, environmental, social and technological challenges of our complex, interdependent world. The pandemic has accelerated systemic changes that were apparent before its inception. The fault lines that emerged in 2020 now appear as critical crossroads in 2021. The Davos Agenda will help leaders choose innovative and bold solutions to stem the pandemic and drive a robust recovery over the next year.

The five programme themes are:

  1. Designing cohesive, sustainable, resilient economic systems (25 January)
  2. Driving responsible industry transformation and growth (26 January)
  3. Enhancing stewardship of the global commons (27 January)
  4. Harnessing the technologies of the Fourth Industrial Revolution (28 January)
  5. Advancing global and regional cooperation (29 January)

Special addresses from G20 heads of state and government and international organizations will provide crucial insights into a range of important issues in the year ahead. Participants will hear first-hand how these public figures will demonstrate leadership and drive action in areas such as the environment, jobs, and advances in innovation brought by the Fourth Industrial Revolution.

Heads of state and government include:

Xi Jinping, President of the People’s Republic of China; Narendra Modi, Prime Minister of India; Yoshihide Suga, Prime Minister of Japan; Emmanuel Macron, President of France; Angela Merkel, Federal Chancellor of Germany; Ursula von der Leyen, President of the European Commission; Giuseppe Conte, Prime Minister of Italy; Moon Jae-in, President of the Republic of Korea; Alberto Fernández, President of Argentina; Cyril Ramaphosa, President of South Africa; Pedro Sánchez, Prime Minister of Spain; Guy Parmelin, President of the Swiss Confederation and Federal Councillor for Economic Affairs, Education and Research; Ivan Duque, President of Colombia; Carlos Alvarado Quesada, President of Costa Rica; Nana Addo Dankwa Akufo-Addo, President of the Republic of Ghana; Kyriakos Mitsotakis, Prime Minister of Greece; Benjamin Netanyahu, Prime Minister of Israel; Abdullah II ibn Al Hussein, King of the Hashemite Kingdom of Jordan; Paul Kagame, President of Rwanda; Lee Hsien Loong, Prime Minister of Singapore, the host of the World Economic Forum Special Annual Meeting 2021.

Other world leaders are expected to confirm.

Leaders from international organizations, government agencies and central banks include:

António Guterres, Secretary-General, United Nations (UN); Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (WHO); Kristalina Georgieva, Managing Director, International Monetary Fund (IMF); Amina Mohammed, Deputy Secretary-General, United Nations (UN); Achim Steiner, Administrator, United Nations Development Programme (UNDP); Phumzile Mlambo-Ngcuka, Undersecretary-General and Executive Director, United Nations Entity for Gender Equality and the Empowerment of Women (UN WOMEN); Dongyu Qu, Director-General, Food and Agriculture Organization of the United Nations (FAO); Inger Andersen, Executive Director, United Nations Environment Programme (UNEP); Henrietta Fore, Executive Director, United Nations Children’s Fund (UNICEF); David Beasley, Executive Director, United Nations World Food Programme (WFP); Fang Liu, Secretary-General, International Civil Aviation Organization (ICAO); Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA; Angel Gurría, Secretary-General, Organisation for Economic Co-operation and Development (OECD); Mauricio Claver-Carone, President, Inter-American Development Bank (IDB); Guy Ryder, Director-General, International Labour Organization (ILO); Jürgen Stock, Secretary-General, International Criminal Police Organization (INTERPOL); Fatih Birol, Executive Director, International Energy Agency (IEA); Rebecca Fatima Sta Maria, Executive Director, APEC Secretariat (Asia-Pacific Economic Cooperation).

Christine Lagarde, President, European Central Bank; François Villeroy de Galhau, Governor of the Central Bank of France; Andrew Bailey, Governor of the Bank of England.

The private sector will be represented by more than 1,000 leaders from the Forum’s member and partner organizations. Seven of the top ten companies by market capitalization are engaged year-round with the Forum and many will participate in The Davos Agenda week. As a working meeting to advance ongoing project work, more than 500 chief executives and chairpersons will take part in sessions throughout the week.

Leaders from civil society are a critical voice in shaping the agenda. Those taking part in the meeting include:

Seth Berkley, Chief Executive Officer, Gavi, the Vaccine Alliance; Gabriela Bucher, Executive Director, Oxfam International; Sharan Burrow, General Secretary, International Trade Union Confederation (ITUC); Hindou Oumarou Ibrahim, President, Association for Indigenous Women and Peoples of Chad (AFPAT); Marco Lambertini, Director-General, WWF International; Laura Liswood, Secretary-General, Council of Women World Leaders; Delia Ferreira Rubio, Chair, Transparency International; Peter Sands, Executive Director, Global Fund to Fight AIDS, Tuberculosis and Malaria (GF). 

Drawn from over 10,000 civic-minded young leaders, members of the World Economic Forum’s Global Shapers, Young Global Leaders, Technology Pioneers and Social Entrepreneurs communities will bring unique perspectives to The Davos Agenda.

Flagship reports, initiatives, and the latest book on Stakeholder Capitalism 

On January 25, Professor Schwab will release his latest book, titled “Stakeholder Capitalism: A Global Economy that Works for Progress, People and Planet.” It explores how societies can build the future post-COVID, and builds on the Forum’s 50-year-old advocacy of the stakeholder approach.

The World Economic Forum will release its Global Risks Report 2021 on 19 January. The flagship report is an important marker for prioritizing action in public and private sectors in the year ahead.

The Davos Agenda will also mark the launch of several World Economic Forum initiatives to accelerate the race to net-zero emissions, to champion new standards for racial justice, to ensure artificial intelligence is developed ethically and in the global public interest and to close the digital divide. More details on these initiatives and others will be disclosed at the meeting.

Opening Event and Crystal Awards

The meeting will be preceded by the Opening Event, available on YouTube on Sunday 24 January at 19.00 CET, featuring a welcome from Klaus Schwab and a special address by Guy Parmelin, President of the Swiss Confederation, just before the 27th Crystal Awards hosted by Hilde Schwab, Chairperson and Co-founder, Schwab Foundation for Social Entrepreneurship, and the photographer Platon.

The awards will be followed by the world premiere of “See Me: A Global Concert.” The official programme of The Davos Agenda will begin on 25 January.

Notes to editors

Media registration and sign-up

Explore the guide on how to follow and embed sessions on your website here

Watch the livestreamed sessions here

Follow the Forum on Twitter via @wef@davos and join the conversation using #DavosAgenda | Instagram | LinkedIn | TikTok | Weibo | Podcasts

Become a fan of the Forum on Facebook

Read the Forum Agenda also in French | Spanish | Mandarin | Japanese

Check out the Forum’s Strategic Intelligence Platform and Transformation Maps

Watch Forum videos

Learn about the Forum’s impact

Subscribe to Forum news releases and Podcasts

SOURCE

From: “<Adrian Monck>”, World Economic Forum <Public.Affairs@weforum.org>

Reply-To: “<Adrian Monck>”, World Economic Forum <Public.Affairs@weforum.org>

Date: Monday, January 18, 2021 at 9:37 AM

To: “Aviva Lev-Ari, PhD, RN” <AvivaLev-Ari@alum.berkeley.edu>

Subject: World Leaders to meet during Davos Agenda in a crucial year to rebuild trust

Read Full Post »


Venture Summit Virtual Connect West, March 16th -18th 2021 featuring a dedicated Lifesciences / Healthcare Track

 

Leaders in Pharmaceutical Business Intelligence

&

youngStartup Ventures

 

UPDATED on 1/21/2021

Leaders in Pharmaceutical Business Intelligence is pleased to announce its sponsorship and invite you to join us at Venture Summit Virtual Connect West, featuring a dedicated Lifesciences / Healthcare Track

Special offer: 20% off Early Bird Rates (Use discount code “LPBIVIP”)

 

* Call for Top Innovators Details below

 

 

Venture Summit Virtual Connect West

Where Innovation Meets Capital

 

March 16th -18th 2021

 

 

Friends,

 

Come meet, interact and network online with more than 1,500 VCs, Corporate VCs, angel investors, industry execs and founders of venture backed, emerging and early stage companies at the prestigious Venture Summit Virtual Connect West being held virtually on March 16th-18th 2021, featuring a dedicated Lifesciences / Healthcare track.

 

Whether you’re a Lifesciences /Healthcare startup seeking capital and exposure, or an investor seeking new deals, the Lifesciences / Healthcare track at Venture Summit Virtual Connect West presented by youngStartup Ventures – is the event of the year you won’t want to miss.

 

A highly productive venture conference, Venture Summit Virtual Connect West will bring together over 1,500 VCs, Corporate VCs, Angel Investors, ‎Industry executives and founders of venture backed, emerging and early stage companies; will feature ‎One-on-One networking (online), more than 150 VCs as speakers/ judges; Venture panels, startup workshops, presentations by more than 100 Top Innovators and ‎Keynotes.

 

Partial roster of over VCs and Angels confirmed to speak and judge:

Bozena Adamczyk, Investment Director, Truffle Capital | Dan Altschuler Malek, Managing Partner, Unovis Asset Management | Doug Atkin, Co-Founder, Managing Partner, Communitas Capital Partners | Sion Balass, Partner, The Group Ventures | Randy Berholtz, Senior Advisor, Mesa Verde Venture Partners | Ned Berman, Senior Associate, Differential Ventures | Udit Bhatnagar, Vice President, McRock Capital | Christopher Booker, Partner, Frist Cressey Ventures | James Carroll, Managing Partner, CC Angel Investments | Kathryn Cartini, Co-founder / Partner, Chloe Capital | Diana Ciobanete, Program Director, Commons Accel | Xiaolei Cong, Vice President, Citi Ventures | Darren Cooke, Investor and Board Member, Life Science Angels | Amy Coveny, Managing Partner, Quake Capital | Joe Darcy, Principal, IDEA Fund Partners | Rahul Daryanani, Investor, Touchdown Ventures | Timur Davis, Principal, Munich Re Ventures | Jun Deng, Investment Partner, Joyance Partners | Philip Deutch, Partner, NGP ETP | Dixon Doll, Co-Founder & Partner Emeritus, DCM Ventures | Vikki Dunn, Operating Partner, Energy Innovation Capital | Amy Dyck, Associate, Framework Venture Partners | Sara Enan, Investment Associate, Global Ventures | Michelle Fan, Founder, Wharton Alumni Angel Network | Ali Farahanchi, Managing Director, DHVC | Andrew Felbinger, Investor, Urban Innovation Fund | Mark Fields, Partner, Alsop Louie Partners | Carolin Funk, Investment Director, Blue Bear Capital | Elena Gantvarg, Principal, Flint Capital | Gary Gershony, Founding General Partner, BayMed Venture Partners | David Goldberg, General Partner, Alpaca VC | Lizzy Goldman, Investment Analyst, Olive Tree Ventures | Emi Gonzalez, Senior Principal, Social Starts | Jay Goss, General Partner, Wavemaker Three-Sixty Health | Michelle Gouveia, Associate, Sandbox Insurtech Ventures | John Gu, Principal, Spring Mountain Capital | Katie Hayes, Director, Wittington Ventures | Robert Hess, Angel Investor, Life Science Angels | Kirsten Horning, Principal, XRC Labs | Ben Jen, Managing Director, Ben Jen Holdings | Hunter Kettering, VC, Red Cedar Ventures | Howard Ko, Principal, Morpheus Ventures | Rachel Lauren, Analyst, Bertelsmann Digital Media Investments | Randall LaVeau, Partner, BOSS Capital Partners | James Lee, Investment Director, Photonfund | Sarah Leners, Senior Associate, Bull City Venture Partners | Alicia Lenis, Vice President, Chrysalix Venture Capital | Todd Lewis, VP, Prologis Ventures, Prologis Ventures | Charles Ling, Investment Director, Tsingyuan Ventures | Jim Lockheed, Principal, JetBlue Technology Ventures | Patrick Lord, Partner – Fintech, Truffle Capital | Eric Lui, Venture Partner, HCG Global Partners | Vincent Lui, Sr. Director Corporate Ventures, SK Telecom Americas | Shailendra Mahajan, Managing Director, Maxim Ventures | Tai Mai, Investment Fellow, MEDA Angels | Shervin Majd, Angel Investor, Life Science Angels | Maulik Mehta, Investor, Arc Ventures | David Mendez, Managing Partner, Good Growth Capital | Laurie Menoud, Partner, At One Ventures | Pedro Mesquita, Investment Analyst, Mindset Ventures | Khash Mohajerani, Director, BWE LLP | Matt Murphy, Partner, Montage Ventures | Molly O’Shea, Investor, NYL Ventures | Hirak Parikh, Fund Manager, Michigan Biomedical Venture Fund | Chris Park, Investment Director, UL Ventures | Daniel Pianko, Managing Director, Achieve Partners | Robert Poor, Advisor, Good Growth Capital | Ulrich Quay, Managing Partner, BMW i Ventures | Suraj Rajwani, Managing Partner, DoubleRock LLC | Krish Ramadurai, Partner, Harmonix Fund | Ashley Ramirez, Chief of Staff and Investor, Halogen Ventures | Amit Rathore, Founding Partner, AwakeVC | Marie-Christine Razaire, Associate, Northwestern Mutual Future Ventures | John Robinson, Partner, Mazarine Ventures | Stephen Roland, Associate, Swiftarc Ventures | Vincent Ruinet, Investment Director, ENGIE New Ventures | Igor Ryabenkiy, Managing Partner, AltaIR Capital | Massimo Schäppi, Partner, Tomahawk .VC | Brian Schuman, Investment Professional, PepsiCo Technology Ventures | Simon Sharp, Principal, Global Ventures | Charles Sidman, Managing Partner, ECS Capital Partners | Ratan Singh, Partner, Fort Ross Ventures | Michelle Snyder, Partner, McKesson Ventures | Peter Sopher, Manager, Clean Energy Ventures | Kumar Sripadam, GP, Elevate Capital | Anish Srivastava, Founder & CEO, Vinaj Ventures | Nancy Sullivan, CEO and Managing Director, Illinois Ventures | Haolin Sung, Managing Partner, Chaperone Investment | Byron Thom, Principal, Framework Venture Partners | Bernhard Ungerbock, Principal, eQventure | Grant Van Cleve, Managing Partner, Hangar 75 Ventures | Jennifer Vancini, General Partner, Mighty Capital | Joe Vasquez, Venture Partner, Revel Partners | Mark Vreeke, Founder, Chemical Angel Network | Jordan Wahbeh, Managing Partner, SV Venture Group | Brian Walsh, Head, WIND Ventures | Tobi Walter, Principal, Cofounders Capital | Lauren Weston, Associate, Thomvest Ventures | Stephanie Zepeda, Principal, Arbor Ventures | Lu Zhang, Founder & Managing Partner, Fusion Fund and many more…

 

 

Special Offer:

Leaders in Pharmaceutical Business Intelligence has made special arrangement for our network to receive a unique discount of an additional 20% off the existing “early bird” savings. This conference will be attended by the best people in the industry. Please register early to avoid disappointment.

 

Register Today & Save Click here http://bit.ly/3840e3D    . (Use promo code “LPBIVIP”)

 

In addition to providing access to leading Investors, the conference will feature more than 100 pre-screened venture backed, emerging and early stage companies seeking capital, and hardcore networking.

 

 

Call for TOP INNOVATORS!

Get Noticed > Get Funded > Grow Faster

 

A select group of more than 100 Top Innovators will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners.

 

Apply to Present / Nominate a company:

For more information or to be considered for one of the Top Innovator slots click here.

 

Seed Pitchfest:

If you are a seed stage company seeking angel funding of less than $1M (and have raised less than $300,000) click here to apply for the Seed stage track.

 

 

We look forward to seeing you there.

 

Leaders in Pharmaceutical Business Intelligence & youngStartup Ventures

 

 

 

Leaders in Pharmaceutical Business Intelligence is pleased to announce its sponsorship and invite you to join us at Venture Summit Virtual Connect West, featuring a dedicated Lifesciences / Healthcare Track

Special offer: 20% off Early Bird Rates (Use discount code “LPBIVIP”)

 

* Call for Top Innovators Details below

  

Venture Summit Virtual Connect West

Where Innovation Meets Capital

 

March 16th -18th 2021

Register Today & Save

Click here http://bit.ly/3840e3D   

(Use promo code “LPBIVIP”)

Friends,

 

Come meet, interact and network online with more than 1,500 VCs, Corporate VCs, angel investors, industry execs and founders of venture backed, emerging and early stage companies at the prestigious Venture Summit Virtual Connect West being held virtually on March 16th-18th 2021, featuring a dedicated Lifesciences / Healthcare track.

Whether you’re a Lifesciences /Healthcare startup seeking capital and exposure, or an investor seeking new deals, the Lifesciences / Healthcare track at Venture Summit Virtual Connect West presented by youngStartup Ventures – is the event of the year you won’t want to miss. 

A highly productive venture conference, Venture Summit Virtual Connect West will bring together over 1,500 VCs, Corporate VCs, Angel Investors, ‎Industry executives and founders of venture backed, emerging and early stage companies; will feature ‎One-on-One networking (online), more than 150 VCs as speakers/ judges; Venture panels, startup workshops, presentations by more than 100 Top Innovators and ‎Keynotes.

 

Partial roster of VCs and Angels confirmed to speak and judge:

Bozena Adamczyk, Investment Director, Truffle Capital | Doug Atkin, Co-Founder, Managing Partner, Communitas Capital Partners | James Carroll, Managing Partner, CC Angel Investments | Kathryn Cartini, Co-founder / Partner, Chloe Capital | Diana Ciobanete, Program Director, Commons Accel | Xiaolei Cong, Vice President, Citi Ventures | Timur Davis, Principal, Munich Re Ventures | Sara Enan, Investment Associate, Global Ventures | Michelle Fan, Founder, Wharton Alumni Angel Network | Andrew Felbinger, Investor, Urban Innovation Fund | Gary Gershony, Founding General Partner, BayMed Venture Partners | Lizzy Goldman, Investment Analyst, Olive Tree Ventures | Jay Goss, General Partner, Wavemaker Three-Sixty Health | Michelle Gouveia, Associate, Sandbox Insurtech Ventures | John Gu, Principal, Spring Mountain Capital | Kirsten Horning, Principal, XRC Labs | Hunter Kettering, VC, Red Cedar Ventures | Rachel Lauren, Analyst, BDMI | Randall LaVeau, Partner, BOSS Capital Partners | James Lee, Investment Director, Photonfund | Sarah Leners, Senior Associate, Bull City Venture Partners | Tai Mai, Investment Fellow, MEDA Angels | Shervin Majd, Angel Investor, Life Science Angels | Matt Murphy, Partner, Montage Ventures | Hirak Parikh, Fund Manager, Michigan Biomedical Venture Fund | Chris Park, Investment Director, UL Ventures | Krish Ramadurai, Partner, Harmonix Fund | Ashley Ramirez, Chief of Staff and Investor, Halogen Ventures | Amit Rathore, Founding Partner, AwakeVC | Vincent Ruinet, Investment Director, ENGIE New Ventures | Igor Ryabenkiy, Managing Partner, AltaIR Capital | Brian Schuman, Investment Professional, PepsiCo Technology Ventures | Simon Sharp, Principal, Global Ventures | Ratan Singh, Partner, Fort Ross Ventures | Michelle Snyder, Partner, McKesson Ventures | Peter Sopher, Manager, Clean Energy Ventures | Anish Srivastava, Founder & CEO, Vinaj Ventures | Nia Stefani, CEO, Xnergy Financial | Nancy Sullivan, CEO and Managing Director, Illinois Ventures | Haolin Sung, Managing Partner, Chaperone Investment | Bernhard Ungerbock, Principal, eQventure | Grant Van Cleve, Managing Partner, Hangar 75 Ventures | Jennifer Vancini, General Partner, Mighty Capital | Brian Walsh, Head, WIND Ventures | Tobi Walter, Principal, Cofounders Capital | Stephanie Zepeda, Principal, Arbor Ventures | Lu Zhang, Founder & Managing Partner, Fusion Fund and many more…

 

Special Offer:

Leaders in Pharmaceutical Business Intelligence has made special arrangement for our network to receive a unique discount of an additional 20% off the existing “early bird” savings. This conference will be attended by the best people in the industry. Please register early to avoid disappointment.

 

Register Today & Save Click here http://bit.ly/3840e3D   

(Use promo code “LPBIVIP”)

 

In addition to providing access to leading Investors, the conference will feature more than 100 pre-screened venture backed, emerging and early stage companies seeking capital, and hardcore networking.

  

Call for TOP INNOVATORS!

Get Noticed > Get Funded > Grow Faster

 

A select group of more than 100 Top Innovators will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners.

Apply to Present / Nominate a company:

For more information or to be considered for one of the Top Innovator slots click here. 

Seed Pitchfest:

If you are a seed stage company seeking angel funding of less than $1M (and have raised less than $300,000) click here to apply for the Seed stage track.

  

We look forward to seeing you there.

 

Leaders in Pharmaceutical Business Intelligence

&

youngStartup Ventures

 

 

 

 

 

LinkedIn

Leaders in Pharmaceutical Business Intelligence invites you to join over 150 leading VCs, Corp VCs, Angel Investors and over 100 Top Innovators at #VSVC Venture Summit Virtual Connect West being held on March 16th– 18th 2021. Dedicated Lifesciences / Healthcare Track, One-on-One (zoom) investor meetings, 2 days of content including timely panel discussions, workshops and an inspiring keynotes. Register here today to confirm your spot: http://bit.ly/3840e3D and save an extra 20% off Early Bird Rates with Discount Code: LPBIVIP.

Whether you are a Lifesciences / Healthcare investor seeking access to new early stage deals, or a CEO or Founder of a new venture looking for funding, visibility and growth, Venture Summit | Virtual Connect is one event you won’t want to miss.

 

Twitter

Join over 150 leading VCs, Corp VCs, Angel Investors and over 100 Top Innovators at #VSVC Venture Summit Virtual Connect West being held on March 16th– 18th 2021. Dedicated Lifesciences/Healthcare Track, One-on-One (zoom) investor meetings, 2 days of content including timely panel discussions, workshops and an inspiring keynotes. Register here today to confirm your spot: http://bit.ly/3840e3D and save an extra 20% off Early Bird Rates with Discount Code: LPBIVIP.

Where do #startups connect with over 150 leading VCs, Corp VCs, Angel Investors and over 100 Top Innovators? #VSVC Venture Summit Virtual Connect West being held on March 16th – 18th 2021. Dedicated Lifesciences / Healthcare Track, One-on-One (zoom) investor meetings, 2 days of content including timely panel discussions, workshops and an inspiring keynotes. Register at  http://bit.ly/3840e3D and save an extra 20% off Early Bird Rates with Discount Code: LPBIVIP.

Facebook

Leaders in Pharmaceutical Business Intelligence invites you to join over 150 leading VCs, Corp VCs, Angel Investors and over 100 Top Innovators at #VSVC Venture Summit | Virtual Connect West being held on March 16th – 18th 2021. Dedicated Lifesciences / Healthcare Track, One-on-One (zoom) investor meetings, 2 days of content including timely panel discussions, workshops and an inspiring keynotes. Register here today to confirm your spot: http://bit.ly/3840e3D and save an extra 20% off Early Bird Rates with Discount Code: LPBIVIP.

 

 

Read Full Post »


Biomolecular Condensates: A new approach to biology originated @MIT – Drug Discovery at DewPoint Therapeutics, Cambridge, MA gets new leaders, Ameet Nathwani, MD (ex-Sanofi, ex-Novartis) as Chief Executive Officer and Arie Belldegrun, PhD (ex-Kite Therapeutics) on R&D

Curator & Reporter: Aviva Lev-Ari, PhD, RN

 

Hooked by the science, Arie Belldegrun joins a group of influentials who believe Dewpoint may have the key to the next big thing in biotech

A new approach to biology

“The real voyage of discovery consists, not in seeking new landscapes, but in having new eyes.” Marcel Proust

Starting with the study of P granules in C.elegans embryos in 2009, Tony Hyman, working with his collaborators like Frank Julicher, Cliff Brangwynne, Simon Alberti, Mike Rosen, and Rohit Pappu, began to unravel the mysteries of biomolecular condensates. These scientists realized that P granules behave like liquid droplets that form by phase separation (think of oil droplets in salad dressing) and called them condensates.

In subsequent studies, they found to their surprise that many compartments inside cells had the behavior of condensates: they are liquid-like and form by phase separation.

Inspired by the work of Tony and his colleagues, Richard Young, Phillip Sharp, and Arup Chakraborty at MIT applied these approaches to the study of gene expression, similarly shedding light on many important questions in gene control.

a video thumbnail

 

Press releases and Dewpoint in the news

 
  • Dewpoint Therapeutics Appoints Ameet Nathwani as Chief Executive Officer

    Dewpoint

  • New York Times interviews Rick Young and Amy Gladfelter on the role of condensate “droplets” in COVID-19

    New York Times

  • Dewpoint Therapeutics raises $77 million to go after ‘undruggable’ diseases

    Boston Globe

  • Hooked by the science, Arie Belldegrun joins a group of influentials who believe Dewpoint may have the key to the next big thing in biotech

    Endpoint News

  • Dewpoint Therapeutics to put ‘pedal to the metal’ with $77M round

    FierceBiotech

  • Dewpoint Therapeutics Raises $77M Series B Financing to Advance the Development of Drugs That Target Biomolecular Condensates

    Dewpoint

  • 21 biotech startups that are set to take off, according to top VCs

    Business Insider

  • Proteins — and labs — coming together to prevent Rett Syndrome

    Whitehead Institute

  • Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV

    Dewpoint

  • Discovery of how cancer drugs find their targets could lead to a new toolset for drug development

    Whitehead Institute

SOURCE

https://dewpointx.com/news/

Other related article published in this Online Open Access Scientific Journal include: 

Economic Potential of a Drug Invention (Prof. Zelig Eshhar, Weitzman Institute, registered the patent) versus a Cancer Drug in Clinical Trials: CAR-T as a Case in Point, developed by Kite Pharma, under Arie Belldegrun, CEO, acquired by Gilead for $11.9 billion, 8/2017.

https://pharmaceuticalintelligence.com/2017/10/04/economic-potential-of-a-drug-invention-prof-zelig-eshhar-weitzman-institute-registered-the-patent-versus-a-cancer-drug-in-clinical-trials-car-t-as-a-case-in-point-developed-by-kite-pharma-unde/

Read Full Post »


Tweet Collection by @pharma_BI and @AVIVA1950 and Re-Tweets for e-Proceedings 14th Annual BioPharma &amp; Healthcare Summit, Friday, September 4, 2020, 8 AM EST to 3-30 PM EST – Virtual Edition

Real Time Press Coverage: Aviva Lev-Ari, PhD, RN

 

e-Proceedings 14th Annual BioPharma & Healthcare Summit, Friday, September 4, 2020, 8 AM EST to 3-30 PM EST – Virtual Edition

Real Time Press Coverage: Aviva Lev-Ari, PhD, RN

Founder & Director, LPBI Group

https://pharmaceuticalintelligence.com/2020/07/28/14th-annual-biopharma-healthcare-summit-friday-september-4-2020-8-am-est-to-3-30-pm-est-virtual-edition/

 

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Hal Barron, Chief Scientific Officer and President R&D, GlaxoSmithKline GWAS not easy to find which gene drives the association  Functional Genomics gene by gene with phenotypes using machine learning significant help

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Hal Barron, Chief Scientific Officer and President R&D, GSK GWAS not easy to find which gene drives the association  Functional Genomics gene by gene with phenotypes using machine learning significant help

Srihari Gopal
@sgopal2

Enjoyed hearing enthusiasm for Neuroscience R&D by Roy Vagelos at #USAIC20. Wonderful interview by Mathai Mammen

Image

1
2
Show this thread

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Nina Kjellson, General Partner, Canaan Data science is a winner in Healthcare Women – Data Science is an excellent match

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Arpa Garay, President, Global Pharmaceuticals, Commercial Analytics, Merck & Co. Data on Patients and identification who will benefit fro which therapy  cultural bias risk aversion

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Najat Khan, Chief Operating Officer, Janssen R&D Data Sciences, Johnson & Johnson Data Validation  Deployment of algorithms embed data by type early on in the crisis to understand the disease

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Sastry Chilukuri, President, Acorn AI- Medidata Opportunities in Data Science in Paharma COVID-19 and Data Science

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Maya Said, Chief Executive Officer, Outcomes4Me Cancer patients taking change of their care Digital Health – consumerization of Health, patient demand to be part of the decision, part the information FDA launched a Program Project Patient Voice

USAIC
@USAIC

We’re taking a quick break at #USAIC20 before our next panel on rare diseases starts at 12:20pm EDT. USAIC would like to thank our Sponsors and Partners for supporting this year’s digital event.

Image

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Roy Vagelos, Chairman of the Board, Regeneron HIV-AIDS: reverse transcriptase converted a lethal disease to a chronic disease, tried hard to make vaccine – the science was not there

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Roy Vagelos, Chairman of the Board, Regeneron Pharmaceuticals Congratulates Big Pharma for taking the challenge on COVID-19 Vaccine, Antibody and anti-viral Government funding Merck was independent from Government – to be able to set the price

1

Dr Kapil Khambholja
@kapilmk

Christopher Viehbacher, Gurnet Point Capital touches very sensitive topic at #USAIC20 He claims that we are never going to have real innovation out of big pharma! Well this isn’t new but not entirely true either… any more thoughts?
1
1
Show this thread

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Daphne Zohar, Founder & CEO, PureTech Health Disease focus, best science is the decision factors

1

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Christopher Viehbacher, Managing Partner, Gurnet Point Capital Dream of every Biotech – get Big Pharma coming to acquire and pay a lot Morph and adapt

anju ghangurde
@scripanjug

Biogen’s chair Papadopoulos big co mergers is an attempt to solve problems; typically driven by patent expirations.. #usaic20

2

anju ghangurde
@scripanjug

Chris Viehbacher/Gurnet Point Capital on US election: industry will work with whoever wins; we’ll have to ‘morph & adapt’ #usaic20

1

Dr Kapil Khambholja
@kapilmk

of

talks about various philosophies and key reasons why certain projects/molecules are killed early. My counter questions- What are chances of losing hope little early? Do small #biopharma publish negative results to aid to the knowledge pool? #USAIC20

Image

2
2
Show this thread

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute DNA repair and epignetics are the future of medicine

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute COlonorectal cancer is increasing immuno therapy 5 drugs marketed 30% cancer patients are treated early detection key vs metastatic 10% of cancer are inherited treatment early

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Rehan Verjee, President, EMD Serono Charities funding cancer research – were impacted and resources will come later and in decreased amount New opportunities support access to Medicine improve investment across the board

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Philip Larsen, Global Head of Research, Bayer AG Repurposing drugs as antiviral from drug screening innovating methods Cytokine storm in OCVID-19 – kinase inhibitors may be antiviral data of tested positive allows research of pathway in new ways

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Laurie Glimcher, President & CEO, Dana-Farber 3,000 Telemedicine session in the first week of the Pandemic vs 300 before – patient come back visits patient happy with Telemedicine team virtually need be reimbursed same rate working remotely

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School New normal as a result of the pandemic role of personalized medicine

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Rehan Verjee, President, EMD Serono entire volume of clinical trials at Roche went down same at EMD delay of 6 month, some were to be initiated but was put on hold Charities funding cancer research were impacted and resources will come later smaller

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute Dana Farber saw impact of COVID-19 on immunosuppressed patients coming in for Cancer Tx – switch from IV Tx to Oral 96% decrease in screenings due to Pandemic – increase with Cancer

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Kenneth Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co. Pharma’s obligation for next generations requires investment in R&D vs Politicians running for 4 years Patients must come first vs shareholders vs R&D investment in 2011

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Kenneth Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co. Antibiotic research at Merck – no market incentives on pricing for Merck to invest in antibiotics people will die from bacterial resistance next pandemic be bacterial

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Kenneth Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co. Strategies of Merck = “Medicine is for the People not for Profit” – Ketruda in India is not reembureable in India and million are in need it Partnership are encouraged

Dr Kapil Khambholja
@kapilmk

Chairman Stelios Papadopoulos asks #KennethFrazier if wealthy nations will try to secure large proportion of #COVID19 drugs/vaccines. #KennethFrazie rightly mentions: pharma industry’s responsibility to balance the access to diff countries during pandemic. #USAIC20

1
3
Show this thread

Dr Kapil Khambholja
@kapilmk

Almost 60% participants at #USAIC20 feel that MNCs are more likely to run their #clinicalTrials in #INDIA seeing changing environment here, reveals the poll. Exciting time ahead for scientific fraternity as this can substantially increase the speed of #DrugDevelopment globally

Clapping hands sign

Image

1
1
Show this thread

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Barry Bloom, Professor & former Dean, Harvard School of Public Health Vaccine in clinical trials, public need to return for 2nd shot, hesitancy Who will get the Vaccine first in the US  most vulnerable of those causing transmission Pharma’s risk

4

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr. Barry Bloom, Professor & former Dean, Harvard School of Public Health Testing – PCR expensive does not enable quick testing is expensive result come transmission occurred Antibody testing CRISPR test based Vaccine in clinical trials

1

Aviva Lev-Ari
@AVIVA1950

#USAIC20 Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals COllaboration effort around the Globe in the Pandemic therapy solutions including Vaccines

Read Full Post »


2020 World Medical Innovation Forum – COVID-19, AI  – Life Science and Digital Health Investments, MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

 

 

 

Life science and digital health investments have continued at a strong pace during the COVID-19 crisis. Senior investment leaders discuss what to expect. Will:

  • social distancing affect deal making?
  • key asset categories remain strong – venture, private equity, public offerings, acquisitions?
  • valuations hold up in some categories while others fall?

Moderator: Roger Kitterman, VP, Venture and Managing Partner, Partners Innovation Fund, Mass General Brigham


Jan Garfinkle
, Founder & Manager Partner, Arboretum Ventures, Chair NVCA

Phillip Gross, Managing Director, Adage Capital Management

Christopher Viehbacher, Managing Partner, Gurnet Point Capital

 

VIEW VIDEOS from the event

https://www.youtube.com/channel/UCauKpbsS_hUqQaPp8EVGYOg

From: “Coburn, Christopher Mark” <CMCOBURN@PARTNERS.ORG>

Date: Tuesday, May 12, 2020 at 6:48 AM

To: “Coburn, Christopher Mark” <CMCOBURN@PARTNERS.ORG>

Subject: REGISTRANT RECAP | World Medical Innovation Forum  

 

Dear World Forum Attendee, 

On behalf of Mass General Brigham CEO Anne Klibanski MD and Forum co-Chairs Gregg Meyer MD and Ravi Thadhani MD, many thanks for being among the nearly 11,000 registrants representing 93 countries, 46 states and 3200 organizations yesterday. A community was established around many pressing topics that  will continue long into the future. We hope you have a chance to examine the attached survey results. There are several revealing items that should be the basis for ongoing discussion. We expect to be in touch regularly during the year. Among the plans is a “First Look” video series highlighting top Mass General Brigham Harvard faculty as well as emerging Harvard investigators.  As promised, we  wanted to also share visual Forum session summaries.  You will be able to access the recordings on the Forum’s YouTube page . The first set will go up this morning

We hope you will join us for the 2021 Forum!  

Thanks again, Chris

e-Proceedings 2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

https://pharmaceuticalintelligence.com/2020/04/22/world-medical-innovation-forum-covid-19-ai-and-the-future-of-medicine-featuring-harvard-and-industry-leader-insights-mgh-bwh-virtual-event-monday-may-11-815-a-m-515-p-m-et/

Tweets & Retweets 2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

https://pharmaceuticalintelligence.com/2020/05/11/tweets-retweets-2020-world-medical-innovation-forum-covid-19-ai-and-the-future-of-medicine-featuring-harvard-and-industry-leader-insights-mgh-bwh-virtual-event-mond/

Read Full Post »


The ”Disruptive Dozen” – Harnessing Technology to Reduce Health Disparities: Twelve mostly likely to have significant impact on healthcare by end of 2021.

 

2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

 

 

 

https://worldmedicalinnovation.org/2020-disruptive-dozen/

VIEW VIDEOS from the event

https://www.youtube.com/channel/UCauKpbsS_hUqQaPp8EVGYOg

From: “Coburn, Christopher Mark” <CMCOBURN@PARTNERS.ORG>

Date: Tuesday, May 12, 2020 at 6:48 AM

To: “Coburn, Christopher Mark” <CMCOBURN@PARTNERS.ORG>

Subject: REGISTRANT RECAP | World Medical Innovation Forum  

 

Dear World Forum Attendee, 

On behalf of Mass General Brigham CEO Anne Klibanski MD and Forum co-Chairs Gregg Meyer MD and Ravi Thadhani MD, many thanks for being among the nearly 11,000 registrants representing 93 countries, 46 states and 3200 organizations yesterday. A community was established around many pressing topics that  will continue long into the future. We hope you have a chance to examine the attached survey results. There are several revealing items that should be the basis for ongoing discussion. We expect to be in touch regularly during the year. Among the plans is a “First Look” video series highlighting top Mass General Brigham Harvard faculty as well as emerging Harvard investigators.  As promised, we  wanted to also share visual Forum session summaries.  You will be able to access the recordings on the Forum’s YouTube page . The first set will go up this morning

We hope you will join us for the 2021 Forum!  

Thanks again, Chris

e-Proceedings 2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

https://pharmaceuticalintelligence.com/2020/04/22/world-medical-innovation-forum-covid-19-ai-and-the-future-of-medicine-featuring-harvard-and-industry-leader-insights-mgh-bwh-virtual-event-monday-may-11-815-a-m-515-p-m-et/

Tweets & Retweets 2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

https://pharmaceuticalintelligence.com/2020/05/11/tweets-retweets-2020-world-medical-innovation-forum-covid-19-ai-and-the-future-of-medicine-featuring-harvard-and-industry-leader-insights-mgh-bwh-virtual-event-mond/

2020 Disruptive Dozen

The ”Disruptive Dozen” results from interviews of one hundred Mass General Brigham senior Harvard faculty followed by a rigorous selection process to identify the twelve mostly likely to have significant impact on healthcare by end of 2021.

Rochelle Walensky, MD

Chief, Infectious Disease, MGH; Professor of Medicine, Harvard Medical School

1.

Battling COVID-19: Maps, Technology, and AI

Mapping the spread of infectious diseases within communities is more important than ever as the novel coronavirus continues to sweep across the globe. Researchers are harnessing AI, technology, and advanced data analytics to map the spread of COVID-19 and identify those infected with the virus.

Watch the #1 disruptive technology in a series of 12.

Thomas Sequist, MD

Chief Patient Experience and Equity Officer, PHS; Professor of Medicine and Health Care Policy, Harvard Medical School

2.

Harnessing Technology to Reduce Health Disparities

Health is determined not just by genes, diet, and exercise, but also by the environments where people live, learn, work, and play. New technologies are emerging to help reduce health disparities and improve health outcomes.

Watch the #2 disruptive technology in a series of 12.

Orhun Muratoglu, PhD

Alan Gary Scholar, Director Harris Orthopaedics Lab, MGH; Professor, Harvard Medical School

4.

Solving the Problem of Infection in Total Joint Replacements

Total joint replacement is an increasingly common procedure. For most patients, recovery is uneventful and lasts a few months, but some experience a much more complicated and painful journey due to infection in the artificial joint. Find out how researchers are harnessing technology to help address this problem.

 

Watch the #4 disruptive technology in a series of 12.

Calum MacRae, MD, PhD

Vice Chair for Scientific Innovation, Department of Medicine, BH; Associate Professor of Medicine, Harvard Medical School

3.

Digital Management of Chronic Disease

Chronic diseases are a major challenge for patients and health care systems alike. In 2016, the U.S. spent over a trillion dollars caring for patients with heart disease, diabetes, cancer and other chronic conditions. Find out how technology could help improve care for these patients — and lower costs.

 

Watch the #3 disruptive technology in a series of 12.

David Scadden, MD

Director, Center for Regenerative Medicine, MGH; Co-Director, Harvard Stem Cell Institute; Gerald and Darlene Jordan Professor of Medicine, Harvard Medical School

7.

New Therapeutic Options for Sickle Cell Disease

Millions of people worldwide suffer from sickle cell disease. While the cause of this debilitating blood disorder has been known for half a century, only two drugs are currently available to treat it. New developments are on the horizon that could help transform the management of a disease that has too often been overlooked.

Watch the #7 disruptive technology in a series of 12.

Patricia Musolino, MD, PhD

Co-Director Pediatric Cerebrovascular Service, MGH; Assistant Professor, Harvard Medical School

6.

Gene Therapies Transform Treatment of Rare, Devastating Diseases

The emergence of the first gene therapies for clinical use signaled a watershed moment in the history of medicine. This treatment modality will do ever more in the coming year for patients, especially those with rare genetic conditions.

Watch the #6 disruptive technology in a series of 12.

Joan Miller, MD

Chief of Ophthalmology, MEE and MGH; Ophthalmologist-in-Chief, BH; David Glendenning Cogan Professor of Ophthalmology and Chair, Department of Ophthalmology, Harvard Medical School

5.

New Tools to Help Aging Eyes and Ears

Like many parts of the body, the eyes and ears can deteriorate with age, making them vulnerable to disease and loss of sensory functions. Find out how new technologies and treatments could help patients and clinicians better protect these organs from age-related decline.

Watch the #5 disruptive technology in a series of 12.

Astrid Weins, MD, PhD

Associate Pathologist, Brigham Health; Assistant Professor, Pathology, Harvard Medical School

10.

Making Cells Larger to See Them More Clearly

Visualizing cells at high-resolution is a cornerstone of modern biology and medicine. For more than a century, as scientists yearned to observe biological structures with greater power and clarity, they built more advanced microscopes. Yet today, even those sophisticated tools have limits. See how researchers are developing a innovative new approach to cell visualization.

Watch the third disruptive technology in a series of 12.

Dennis Selkoe, MD

Co-Director of the Ann Romney Center for Neurologic Diseases, Brigham Health; Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical School

9.

First Disease-Modifying Therapy for Alzheimer’s Disease

The world lacks a meaningful treatment for Alzheimer’s disease, a progressive, debilitating neurodegenerative condition that affects millions across the globe. But that could change later this year, when the FDA is expected to weigh in on a novel drug that targets clumps of protein in the brain known as amyloid plaques. If approved, the drug would mark the first disease-modifying therapy for Alzheimer’s disease.

Watch the fourth disruptive technology in a series of 12.

Leonardo Riella, MD, PhD

Medical Director, Vascularized Composite Tissue Transplantation, Brigham Health; Associate Physician, Harvard Medical School

8.

Keeping Transplant Organs Fresher for Longer

Over 120,000 people in this country are now waiting for an organ transplant. What if it were possible to increase the time that organs can be safely stored outside the body prior to transplantation? Scientists are working to drive innovation in this area in an effort to expand the pool of donor organs available for those who need them.

Watch the fifth disruptive technology in a series of 12.

Read Full Post »


Leaders in Pharmaceutical Business Intelligence (LPBI) Group is pleased to invite you to youngStartup Ventures “Where Innovation Meets Capital” – First Round of VC Firms Announced, August 4th – 6th, 2020.

First Round of VC Firms Announced

Second Virtual Summit to feature over 100 VCs

Friends,

We’re pleased to announce the first round of VCs confirmed to be featured at Venture Summit Virtual Connect | Global being held on August 4th – 6th, 2020.

This exclusive venture summit will bring together over 1,300 VCs, corporate VCs, angel investors, industry executives, and founders of venture-backed, emerging, and early-stage companies, will feature more than 100 leading VCs, presentations by 100 cutting-edge innovators, and high-level networking opportunities.

Register Now to lock in the lowest rates possible. Click here

Submit your company for the opportunity to present to leading investors: Click here

 

Connect with leading early stage VCs

 

Susan Akbarpour

Partner

Candou Ventures

Sep Alavi

Venture Partner

White Star Capital

Grant Allen

General Partner

Schneider Electric Ventures

Logan Allin

General Partner

Fin Venture Capital

Milad Alucozai

Partner

Good AI Capital

Amolak Badesha

Investor

Sand Hill Angels

Wade Bitaraf

Founder, Energy & Sustainability

Plug & Play Tech Center

Greg Bohlen

Managing Director

Union Grove Venture Partners

Christophe Bourque

General Partner

White Star Capital

Daniel Burstein

Managing Partner

Millennium Technology Value Partners

Adam Carson

Operating Partner

Point72 Ventures

Jeffrey Cherry

Co-Founder & Executive Director

Conscious Venture Lab

Elizabeth Cho-Fertikh

Cofounder & Managing Director

MEDA Angels

Andy Clapp

Managing Partner

Arctaris Capital Partners

Jay Crone

Director, Investments

TELUS Ventures

Lake Dai

Partner

LDV Partners

Angelo Del Priore

Partner

HP Tech Ventures

Jun Deng

Investment Partner

Joyance Partners

Robert Dunkle

Founder and CEO

ABES Venture Partners

Amy Dyck

Associate

Framework Venture Partners

Nick Efstratis

Managing Director

EPIC Ventures

Mark Farrell

Managing Director

Thayer Ventures

Andrew Felbinger

Investor

Urban Innovation Fund

Constance Freedman

Managing Partner

Moderne Ventures

Isabelle Freidheim

Managing Partner

Starwood VC

Stan Fung

Managing Director

FarSight Ventures

Norm Gitis

Managing Partner

Lymo Ventures

Ajay Gopal

Principal

Framework Venture Partners

Robert Hamlin

Principal

Portag3 Ventures

Florian Haupt

Partner

TruVenturo

Ben Jen

Investor

Ben Jen Holdings

Najib Khouri-Haddad

General Partner

Sway Ventures

Ryan Kole

Partner

VCapital

Elaine Kunda

Founder, Managing Director

Disruption Ventures

Eddie Lee

Principal

White Star Capital

James Lee

Director

Photon Fund Venture Capital

Jessica Li

Investor

Soma Capital

Ephraim Lindenbaum

Managing Director

Advance Ventures

Darwin Ling

Founding General Partner

Good AI Capital

Edwin Loredo

Vice President

Core Innovation Capital

Wasim Malik

Managing Partner

Iaso Ventures

Eugene Malobrodsky

Venture Partner

One Way Ventures

Eric Martineau-Fortin

Co-Founder and Managing Partner

White Star Capital

Philip Mertens

Associate

DSM Venturing

Ivan Nikkhoo

Managing Partner

Navigate Ventures

Carlos Ochoa

Managing Partner

AI8 VENTURES

Valerie Photos

Operating Partner

Iaso Ventures

Filipe Portela

Managing Partner

COREangels Atlantic

Safa Rashtchy

Managing Director

Think + Ventures

John Ricci

Managing Director

US Angels

Alex Rozenfeld

Managing Director

Climate Impact Capital

Gayatri Sarkar

Managing Partner

Hype Capital VC Fund

Brian Schuman

Investment Professional

PepsiCo Technology Ventures

Kristina Serafim

Managing Director

Verizon Ventures

Greg Shepard

Managing Partner

BOSS Capital Partners

Charles Sidman

Managing Partner

ECS Capital Partners

Sean Simpson

Director

WIND Ventures

Jean Sini

General Partner

Partech

Mark A. Solovy

Managing Director

Monroe Capital

Vivek Soni

General Partner

S Cap Cleantech Fund

Kat Utecht

Managing Partner

Core Innovation Capital

Jordan Wahbeh

Managing Partner

SV Venture Group

Henry Wong

Managing Partner

Diamond Tech Ventures

Stephanie Zepeda

Senior Associate

Arbor Ventures

We’re just getting started, more to be announced!

CALL FOR

TOP INNOVATORS!

Get Noticed > Get Funded > Grow Faster

A select group of more than 100 Top Innovators from the fintech, technology, clean-tech, life sciences/healthcare, medical devices, healthcare IT, and mobile sectors will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners!

First Round Submission Deadline for presenting company applications is TODAY June 11th, 2020.

To apply, your company must be privately held and ideally come from one of the following industry sectors:

Tech

Life Sciences / Healthcare

CleanTech

FinTech

EdTech

Hardware

Internet/Digital Media

IoT

Mobile

Security

Software/IT

Biotech

Diagnostics

Drug Discovery

Healthcare IT

Medical Devices

Pharma

Energy Efficiency

Energy Generation

Energy Infrastructure

Energy Storage

Transportation

Water & Wastewater

Banking

Blockchain

Insurtech

Personal Finance

Payments

Predictive Analytics

 

Questions about presenting? Email Preston Michaels at iwant2present (at) youngstartup .co

Seed Stage Track

If you are a seed-stage company seeking angel funding and would like to present check out our seed stage track.

If you’re seeking less than $1M (and have raised less than $300,000) this is for you.

Joe Benjamin

Founder & CEO

youngStartup Ventures

“Where Innovation Meets Capital”

Don’t hesitate to connect with me personally via LinkedIn and request to join our venture network LinkedIn group below.

August 4-6, 2020

  Contact

  youngstartup.com/vcglobal

  info@youngstartup.co  

   212.202.1002

@@@@@

Save 20% with discount code LPBI-VIP

NEW DATE

May 5 – 7, 2020

UPDATED on 4/21/2020

Leaders in Pharmaceutical Business Intelligence (LPBI) Group invites you to join leading VCs, Corp VCs, Angel Investors and over 100 Top Innovators at #VSVC Venture Summit | Virtual Connect being held on May 5th– 7th 2020. One-on-One (zoom) investor meetings, 2 days of content including timely panel discussions, workshops and an inspiring keynote by non-other than Uri Levine, co-founder of Waze  Register here today to confirm your spot: http://bit.ly/2PfsbM7  35% off with Discount Code: LPBI-VIP. #StayHomeSaveLives

Whether you are an investor seeking access to new early stage deals, or a CEO or Founder of a new venture looking for funding, visibility and growth, Venture Summit | Virtual Connect is one event you won’t want to miss.

 

Twitter

Join leading VCs, Corp VCs, Angel Investors and over 100 Top Innovators at #VSVC Venture Summit | Virtual Connect being held on May 5th– 7th 2020. One-on-One (zoom) investor meetings, 2 days of content including timely panel discussions, workshops and an inspiring keynote by non-other than Uri Levine, co-founder of Waze. Register here today to confirm your spot: http://bit.ly/2PfsbM7  35% off with Discount Code: LPBI-VIP. #StayHomeSaveLives

 

Where do #startups connect with leading VCs, Corp VCs, Angel Investors and over 100 Top Innovators? #VSVC Venture Summit | Virtual Connect being held on May 5th– 7th 2020. One-on-One (zoom) investor meetings, 2 days of content including timely panel discussions, workshops and an inspiring keynote by non-other than Uri Levine, co-founder of Waze. Register at  http://bit.ly/2PfsbM7 and get 35% off with Discount Code: LPBI-VIP. #StayHomeSaveLives

  

Facebook

Leaders in Pharmaceutical Business Intelligence (LPBI) Group invites you to join leading VCs, Corp VCs, Angel Investors and over 100 Top Innovators at #VSVC Venture Summit | Virtual Connect being held on May 5th– 7th 2020. One-on-One (zoom) investor meetings, 2 days of content including timely panel discussions, workshops and an inspiring keynote by non-other than Uri Levine, co-founder of Waze. Register here today to confirm your spot: http://bit.ly/2PfsbM7  35%  off with Discount Code: LPBI-VIP. #StayHomeSaveLives

 

 

@@@@ 

Venture Summit \ Virtual Connect

Where Innovation Meets Capital

May 5 – 7, 2020

 

Join early stage VCs, Corporate VCs, Angel Investors and founders of venture backed, emerging and early stage companies at Venture Summit \ Virtual Connect on May 5-7 2020.

 

Whether you’re a startup seeking capital and exposure, or an investor seeking new deals, Venture Summit \ Virtual Connect is one event you won’t want to miss.

 

A highly productive venture conference, Venture Summit \ Virtual Connect will feature:

 

  • Over 100 VCs (regional and national)
  • Presentations by 100 Top Innovators
  • One-on-One (zoom) investor + startup meetings
  • 2 days of content including timely panel discussions and workshops
  • Keynote: Uri Levine, co-founder of Waze

 

Special Offer:

Leaders in Pharmaceutical Business Intelligence (LPBI) Group has made special arrangement for our network to receive 20% off with discount code LPBI-VIP (Note: Rates will go up this Thursday at midnight but the discount will still apply).

 

Register Today & Save Click here http://bit.ly/2PfsbM7.   

 

Over 100 Investors Confirmed:

11.2 Capital, 500 Startups, ABES Venture Partners, Activate Capital, Advance Ventures, Aligned Partners, Alliance of Angels, Alliance Ventures, Alpha Square Group, American Family Ventures, AMINO Capital, Anzu Partners, Arbor Ventures, ARIE Capital, Asset Management Ventures, Augment Ventures, Avestria Ventures, BAM Ventures, Band of Angels, Bay Angels, Bee Partners, Ben Jen Holdings, Benhamou Global Ventures, Better Ventures, Blue Bear Capital, Blue Bear Ventures, Blue Startups, BlueRun Ventures, Boehringer Ingelheim Venture Fund, Boeing HorizonX Ventures, Brand New Matter, Candou Ventures , Catapult VC, Charles River Ventures, CIG CAP, Citi Ventures, City Light Capital, Clean Energy Venture Group, Communitas Capital Partners, Core Innovation Capital, COREangels Atlantic, Costanoa Ventures, Cottonwood Technology Fund, CRCM Ventures, Crestlight Ventures, Data Collective, Deutsche Telekom Capital Partners, DHVC, DigitalDX Ventures, Disruption Ventures, Dow Ventures, DPH Ventures, DSM Venturing, DXA Investments, Dynamk Capital, E. ON , E8 Angels, ECS Capital Partners, Elevate Ventures, Energy Foundry, Energy Innovation Capital, ENGIE New Ventures, Eudemian Ventures, Evok Innovations, F-Prime Capital, Fidelity Investments, Financial Venture Studio, FinSight Ventures, Fort Ross Ventures, Foundation Capital, Framework Venture Partners, Galaxy Digital, Garage Technology Ventures, GM Ventures, Good AI Capital, Good Growth Capital, H.I.G. Growth Partners, Halogen Ventures, Harvard Business School Angels, HealthTech Capital, Henkel Ventures, HP Tech Ventures, Hype Capital VC Fund, Insight Partners, JetBlue Technology Ventures, Johnson & Johnson Innovation – JJDC, Journey Venture Partners, Joyance Partners, Juniper Networks, K5 Ventures, Kubera Venture Capital, Lam Capital, Life Science Angels, Lymo Ventures, Magnet Ventures, ManchesterStory Group, Marcy Venture Partners, McKesson Ventures, Mighty Capital, Millennium Technology Value Partners, Moderne Ventures, Morpheus Ventures, Munich Re Ventures, MVM Partners, National Science Foundation, Navigate Ventures, NEA, New Science Ventures, New York Life Ventures, NextGen Venture Partners, NextWorld Capital, Nielsen Innovate, OCA Ventures, One Way Ventures, Owl Ventures, Pangaea Ventures, Paypal Ventures, Photon Fund, Pipeline Angels, Plug & Play Tech Center, Point72 Ventures, Portag3 Ventures, Portfolia, Prelude Ventures, PROOF VC, Revel Partners, SABIC Ventures, Samsung Catalyst Fund, Sand Hill Angels, Santander InnoVentures, Saudi Angel Fund, Shasta Ventures, SignalFire, Social Impact Capital, Spike Ventures, Starwood VC, Sunrise Capital Partners, Sway Ventures, Tech Coast Angels, The Westly Group, TiE Angels, TruVenturo, UL Ventures, Union Grove Venture Partners, Unusual Ventures, US Angels, Verizon Ventures, Viridian Capital, VisionPassage, Volvo Cars Tech Fund, WAVE Equity Partners, Wharton Alumni Angels More to be announced.

 

More details: http://bit.ly/2PfsbM7

 

We look forward to seeing you there. 

 

Leaders in Pharmaceutical Business Intelligence (LPBI) Group & youngStartup Ventures

 

OLD CONTENT

NEW DATE  Venture Summit | West – “Where Innovation Meets Capital”, May 5 – 7, 2020,

Santa Clara Convention Center, Silicon Valley

VSW20 – Discount code, LPBI-VIP and unique event site link http://bit.ly/2PfsbM7.

Video link for most recent event http://bit.ly/2LQpONN 

 

UPDATED on 3/25/2020

The dedicated discount code LPBI-VIP and unique event site link http://bit.ly/2PfsbM7 now entitles LPBI network to $350 off the current rates. Applicants should register as soon as possible to lock in the lowest possible rates.

We will be hosting 1on1 startup and investor meetings live at Venture Summit | West [digital edition] online in May. The summit will now be expanded for featured companies to 3 days, May 5th – 7th (coaching session + 2 days of content and one on one sessions) and for general attendees to 2 days.

The summit will feature over 150 venture funds as speakers/judges (many others in attendance), more than 100 Top Innovators as presenters, effective and seamless 1:1 meetings + chat, and high-level networking opportunities.

The screening committee is currently interviewing companies and will be selecting more than 100 Top Innovators to present live to the investors at the summit.

Featured Confirmed VC Speakers & Judges:

Kira Noodleman

Bee Partners

 

Kira enjoys tackling problems in disruptive industries and across cultures. Her appreciation for skillful risk-taking attracted her to entrepreneurship, and ultimately to her role in venture capital. At Bee Partners, she spends the majority of her time identifying and investing in Founders and startups servicing enterprises and enabling new marketplaces. She dedicate the remainder of […] Read more

Li Sun

Foundation Capital

 

Li Sun comes from a global background spanning four countries with diverse experiences across engineering, science, technology, and entrepreneurship. She holds a B.Eng in EE and business (1st class honors) from NTU in Singapore, an M.Eng in Materials Science from MIT, and a PhD in Applied Physics from Harvard. During her PhD, she cofounded and […] Read more

Bill Reichert

Garage Technology Ventures

 

Bill Reichert is co-founder and Managing Director of Garage Technology Ventures, a seed and early stage venture capital firm based in Silicon Valley. He is also a Partner at Pegasus Tech Ventures, a global venture capital firm with offices in Silicon Valley and around the world. Bill and his partners invest in promising emerging technology […] Read more

Charlie Hanna

Marcy Venture Partners

 

Charlie Hanna is an investor at Marcy Venture Partners (MVP) in San Francisco, an early-stage venture capital firm co-founded by Larry Marcus, Jay Brown and Jay-Z. Charlie’s focus is consumer products and services with an emphasis on sustainability, accessibility and culture. Prior to MVP, Charlie was an Associate at SWAT Equity Partners, a NYC-based venture […] Read more

SC Moatti

Mighty Capital

 

SC Moatti is the managing partner of Mighty Capital, a Silicon Valley venture capital firm, and Products That Count, one of the largest communities of product managers, leaders and entrepreneurs in the world. Previously, she built products that billions of people use at Facebook, Nokia and Electronic Arts. She also serves on boards of both […] Read more

Mario Ruiz

Paypal Ventures

 

Mario Ruiz is a financial technology investor at PayPal Ventures, focusing on investments in the U.S. and internationally. Prior to joining PayPal, Mario was an investor at Napier Park, where he was a member of a nine-person investment team responsible for the evaluation, diligence, and execution of growth equity and real asset investments. Mario started […] Read more

Danny Cotter

The Westly Group

 

Danny Cotter serves as Principal at The Westly Group. Prior to joining the Westly Group, He worked at Pacific Gas & Electric Company where he focused on discovering advanced technology pilots and analyzing regulatory, competitive and technology landscapes to shape smart grid strategies across the organization. While at PG&E, He also helped lead the development […] Read more

 

UPDATED on 2/26/2020

The dedicated discount code LPBI-VIP and unique event site link http://bit.ly/2PfsbM7 now entitles LPBI network to $350 off the current rates. Applicants should register as soon as possible to lock in the lowest possible rates.

Updated list of over 130 VCs and Angels confirmed to speak and judge. 

 

Partial Lineup of over 130 VCs & Angels confirmed to speak and judge includes:

Ben Abadi, Managing Director, Energy Innovation Capital | Andrew Abrams, Vice President, New Science Ventures | Susan Akbarpour, Partner, Candou Ventures | Joel Albarella, Founder, New York Life Ventures | Navid Alipour, Co-founder and Managing Partner, Analytics Ventures | Shaun Arora, Founding Partner, MiLA Capital | Doug Atkin, Managing Partner, Communitas Capital Partners | Shannon Austin, Partner, Financial Venture Studio | Jennifer Azapian, Partner , Mighty Capital | Mike Biddle, Managing Director, Evok Innovations | Wade Bitaraf, Founder, Energy & Sustainability, Plug & Play Tech Center | Dave Blivin, Managing Director, Cottonwood Technology Fund | Greg Bohlen, Managing Director, Union Grove Venture Partners | Maureen Boyce, Managing Partner, Good Growth Capital | Peter Bruce-Clark, Partner, Social Impact Capital | Pratik Budhdev, Investment Director, Volvo Cars Tech Fund | Amy Burr, Managing Director, JetBlue Technology Ventures | Ray Chan, Managing Director, K5 Ventures | Ryan Chou, Investment Associate, JetBlue Technology Ventures | Darren Cooke, Investor, Life Science Angels | Martha Cosgrove, Investing Associate, Boeing HorizonX | Danny Cotter, Principal, The Westly Group | Ross Darwin, Principal, Owl Ventures | Anne DeGheest, Founder, HealthTech Capital | Angelo Del Priore, Partner, HP Tech Ventures | Jun Deng, Partner, Joyance Partners | Dan Doble, Managing Director, SABIC Ventures | Ted Driscoll, Managing Partner, DigitalDX Ventures | Robert Dunkle, President, ABES Venture Partners | Ali Farahanchi, Director, DHVC | Anna Fokina, Senior Associate, Data Collective | Isabelle Freidheim, Co-founder & Managing Partner, Starwood VC | Emily Fritze, Senior Associate, The Westly Group | Will Fung, Senior Associate, Samsung Catalyst Fund | Norm Gitis, Managing Partner, Lymo Ventures | Ajay Gopal, Founding Principal, Framework Venture Partners | Daniel Greene, Principal, Wipro Ventures | Sheeraz Haji, Managing Partner, Zip Dragon Ventures | Charlie Hanna, Investor, Marcy Venture Partners | Daniel Harris, Managing Director, DPH Ventures | Florian Haupt, Partner, TruVenturo | Guy Horowitz, Partner, Deutsche Telekom Capital Partners | Jens Horstmann, Founding Director, Crestlight Ventures | Michael Julve, Associate, 500 Startups | Najib Khouri-Haddad, General Partner, Sway Ventures | Howard Ko, Principal, Morpheus Ventures | Shruti Kothari, Director, Kaiser Permanente Ventures | Elaine Kunda, Founder & Managing Director, Disruption Ventures | Ricky Lai, Principal, Portag3 Ventures | Anh Le, Partner, CRCM Ventures | James Lee, Investment Associate Director, Photon Fund | Marina Levinson, Partner, Benhamou Global Ventures | Larry Li, Managing Partner, AMINO Capital | Darwin Ling, Founding General Partner, Good AI Capital | Catherine Lu, Managing Partner , Alumni Ventures Group (AVG) | Vincent Lui, Partner, XCEL Asia | Hector MacQuarrie, Senior Investment Associate, Shell Ventures | Radhika Malik, Investment Manager, Samsung Catalyst Fund | Ricky Margolis, VP of Business Development, ARIE Capital | Melina Mathur, Principal, Asset Management Ventures | Manan Mehta, Founding Partner, Unshackled Ventures | Eric Meyer, Vice President, Activate Capital | Jonathan Mo, Senior Associate, 11.2 Capital | SC Moatti, Managing Partner, Mighty Capital | Mark Mueller-Eberstein, Angel Investor, Alliance of Angels | Maxim Nazarov, Investor, FinSight Ventures | Ivan Nikkhoo, Managing Partner, Navigate Ventures | Kira Noodleman, Principal, Bee Partners | Brett Noyes, Founder & Managing Director, Unbank. Ventures | Demi Obayomi, Investor, NextWorld Capital | Nihar Patel, General Partner, Journey Venture Partners | Charles Paul, Vice President – Technology, Henkel Ventures | Damien Petty, Principal, Morpheus Ventures | Patrick Pfeffer, Lead Investor, Juniper Networks | Scott Pinizzotto, Senior Investment Director, ENGIE New Ventures | Bill Reichert, Managing Director, Garage Technology Ventures | Mario Ruiz, Investor, Paypal Ventures | Ernst Sack, Partner, Blue Bear Capital | Praveen Sahay, Managing Director, WAVE Equity Partners | Gayatri Sarkar, Managing Partner, Hype Capital VC Fund | Jordan Segall, Enterprise Investor, Unusual Ventures | Kristina Serafim, Managing Director, Verizon Ventures | Charles Sidman, Managing Partner, ECS Capital Partners | Sean Simpson, Investment Manager, GM Ventures | Ratan Singh, Principal, Fort Ross Ventures | Kenn So, Associate, Shasta Ventures | Allison Steitz, Investor, BlueRun Ventures | Li Sun, Partner, Foundation Capital | Jessica Tan, Associate, 500 Startups | Grahme Taylor, Venture Analyst, Wildcat Venture Partners | Jonathan Tower, Founding Managing Partner, Catapult VC | Erica Van, Investor, Charles River Ventures | Anuj Varma, Investor, BAM Ventures | Kutral Veerabadran, Principal, Flow Capital | Alessandro Vigilante, Head of Global Innovation Ecosystem, Fidelity Investments | Sonali Vijayavargiya, Managing Director, Augment Ventures | Alex Whitney, Senior Analyst, ManchesterStory Group | Henry Wong, Managing Director, Garage Technology Ventures | Joanne Wong, General Partner, REDDS Capital | Russell Yue, Investor, H.I.G. Growth Partners | Elaine Zelby, Principal & Director of Growth, SignalFire | Stephanie Zepeda, Senior Associate, Arbor Ventures | Yanan Zhao, General Partner, Magnet Ventures | Sebastian Zhou, Investor, Alpha Square Group | Simin Zhou, VP & Managing Director, UL Ventures and many more…

 

 

UPDATED on 2/6/2020

Leaders in Pharmaceutical Business Intelligence (LPBI ) Group is pleased to spons and invite you to join us at Venture Summit | West

Special offer:  Register Now & Save $450 off (Use discount code “LPBI-VIP”)

* Call for Top Innovators Details below

Venture Summit | West

Where Innovation Meets Capital

March 23rd & 24th  2020

Santa Clara Convention Center, Silicon Valley

 

Reminder to register for the prestigious Venture Summit | West being held on March 23rd & 24th 2019 at the Santa Clara Convention Center. This year will again feature a dedicated Lifesciences/Healthcare Track. Come meet, interact and network with more than 1,300 VCs, Corporate VCs, angel investors, industry execs and founders of venture backed, emerging and early stage companies.

 

Whether you’re a Lifesciences/Healthcare startup seeking capital and exposure, or an investor seeking new deals, Venture Summit West presented by youngStartup Ventures – is the event of the year you won’t want to miss.

 

A highly productive venture conference, Venture Summit | West is dedicated to showcasing VCs, Corporate VCs and angel investors committed to funding venture backed, emerging and early stage companies.

 

Partial Initial Lineup of over 90 VCs & Angels confirmed to speak and judge includes:

Ben Abadi, Managing Director, Energy Innovation Capital | Andrew Abrams, Vice President, New Science Ventures | Susan Akbarpour, Partner, Candou Ventures | Navid Alipour, Co-founder and Managing Partner, Analytics Ventures | Shaun Arora, Founding Partner, MiLA Capital | Shannon Austin, Partner, Financial Venture Studio | Jennifer Azapian, Partner , Mighty Capital | Wade Bitaraf, Founder, Energy & Sustainability, Plug & Play Tech Center | Dave Blivin, Managing Director, Cottonwood Technology Fund | Greg Bohlen, Managing Director, Union Grove Venture Partners | Maureen Boyce, Managing Partner, Good Growth Capital | Peter Bruce-Clark, Partner, Social Impact Capital | Pratik Budhdev, Investment Director, Volvo Cars Tech Fund | Darren Cooke, Investor, Life Science Angels | Martha Cosgrove, Investing Associate, Boeing HorizonX | Danny Cotter, Principal, Westly Group | Ross Darwin, Principal, Owl Ventures | Anne DeGheest, Founder, HealthTech Capital | Jun Deng, Partner, Joyance Partners | Dan Doble, Managing Director, SABIC Ventures | Robert Dunkle, President, ABES Venture Partners | Ali Farahanchi, Director, DHVC | Anna Fokina, Senior Associate, Data Collective | Norm Gitis, Managing Partner, Lymo Ventures | Daniel Greene, Principal, Wipro Ventures | Sheeraz Haji, Managing Partner, Zip Dragon Ventures | Charlie Hanna, Investor, Marcy Venture Partners | Daniel Harris, Managing Director, DPH Ventures | Florian Haupt, Partner, TruVenturo | Guy Horowitz, Partner, Deutsche Telekom Capital Partners | Jens Horstmann, Founding Director, Crestlight Ventures | Najib Khouri-Haddad, General Partner, Sway Ventures | Howard Ko, Principal, Morpheus Ventures | Shruti Kothari, Director, Kaiser Permanente Ventures | Elaine Kunda, Founder & Managing Director, Disruption Ventures | Ricky Lai, Principal, Portag3 Ventures | Anh Le, Partner, CRCM Ventures | James Lee, Investment Associate Director, Photon Fund | Marina Levinson, Partner, Benhamou Global Ventures | Larry Li, Managing Partner, AMINO Capital | Darwin Ling, Founding General Partner, Good AI Capital | Catherine Lu, Managing Partner , Alumni Ventures Group (AVG) | Vincent Lui, Partner, XCEL Asia | Melina Mathur, Principal, Asset Management Ventures | Manan Mehta, Founding Partner, Unshackled Ventures | Eric Meyer, Vice President, Activate Capital | Jonathan Mo, Senior Associate, 11.2 Capital | SC Moatti, Managing Partner, Mighty Capital | Mark Mueller-Eberstein, Angel Investor, Alliance of Angels | Ivan Nikkhoo, Managing Partner, Navigate Ventures | Kira Noodleman, Principal, Bee Partners | Brett Noyes, Founder & Managing Director, Unbank.Ventures | Charles Paul, Vice President – Technology, Henkel Ventures | Damien Petty, Principal, Morpheus Ventures | Patrick Pfeffer, Lead Investor, Juniper Networks | Scott Pinizzotto, Senior Investment Director, ENGIE New Ventures | Bill Reichert, Managing Director, Garage Technology Ventures | Mario Ruiz, Investor, Paypal Ventures | Ernst Sack, Partner, Blue Bear Capital | Praveen Sahay, Managing Director, WAVE Equity Partners | Gayatri Sarkar, Managing Partner, Hype Capital VC Fund | Kristina Serafim, Managing Director, Verizon Ventures | Charles Sidman, Managing Partner, ECS Capital Partners | Ratan Singh, Principal, Fort Ross Ventures | Allison Steitz, Investor, BlueRun Ventures | Li Sun, Partner, Foundation Capital | Grahme Taylor, Venture Analyst, Wildcat Venture Partners | Jonathan Tower, Founding Managing Partner, Catapult VC | Erica Van, Investor, Charles River Ventures | Anuj Varma, Investor, BAM Ventures | Kutral Veerabadran, Principal, Flow Capital | Sonali Vijayavargiya, Managing Director, Augment Ventures | Alex Whitney, Senior Analyst, ManchesterStory Group | Henry Wong, Managing Director, Garage Technology Ventures | Russell Yue, Investor, H.I.G. Growth Partners | Elaine Zelby, Principal & Director of Growth, SignalFire | Stephanie Zepeda, Senior Associate, Arbor Ventures | Yanan Zhao, General Partner, Magnet Ventures | Sebastian Zhou, Investor, Alpha Square Group | Simin Zhou, VP & Managing Director, UL Ventures and many more.

 

Special Offer:

LPBI has made special arrangement for our network to receive a special discount of $450 off. This conference will be attended by the best people in the industry. Please register early to avoid disappointment.

 

Register Today & Save Click here.   (Use promo code “ LPBI-VIP”)

 

In addition to providing access to leading Investors, the conference will feature more than 100 pre-screened venture backed, emerging and early stage companies seeking capital, and hardcore networking.

 

 

Call for TOP INNOVATORS!

Get Noticed > Get Funded > Grow Faster

 

A select group of more than 100 Top Innovators will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners.

 

Apply to Present / Nominate a company:

For more information or to be considered for one of the Top Innovator slots click here.

 

Seed Pitchfest:

If you are a seed stage company seeking angel funding of less than $1M (and have raised less than $300,000) click here to apply for the Seed stage track.

 

Volunteer Opportunities:

Students and recent alumni are to volunteer to help out for part of the day and enjoy the summit for the other part. Volunteers assist with setup, registration, program coordination, company presentations etc. To join us as a volunteer, please fill out the form here: Click Here http://bit.ly/VSW20VOLUNTEER .

 

 

UPDATED on 1/16/2020

Leaders in Pharmaceutical Business Intelligence (LPBI ) Group is pleased to sponsor and invite you to join us at Venture Summit | West

Special offer:  Register Now & Save $450 off (Use discount code “LPBI-VIP”)

* Call for Top Innovators Details below

Venture Summit | West

Where Innovation Meets Capital

March 23rd & 24th  2020

Santa Clara Convention Center, Silicon Valley

  

Reminder to register for the prestigious Venture Summit | West being held on March 23rd & 24th 2019 at the Santa Clara Convention Center. This year will again feature a dedicated Lifesciences/Healthcare Track. Come meet, interact and network with more than 1,300 VCs, Corporate VCs, angel investors, industry execs and founders of venture backed, emerging and early stage companies.

 

Whether you’re a Lifesciences/Healthcare startup seeking capital and exposure, or an investor seeking new deals, Venture Summit West presented by youngStartup Ventures – is the event of the year you won’t want to miss.

 

A highly productive venture conference, Venture Summit | West is dedicated to showcasing VCs, Corporate VCs and angel investors committed to funding venture backed, emerging and early stage companies.

 

Partial Initial Lineup of over 60 VCs & Angels confirmed to speak and judge includes:

Ben Abadi, Managing Director, Energy Innovation Capital | Shaun Arora, Founding Partner, MiLA Capital | Shannon Austin, Partner, Financial Venture Studio | Jennifer Azapian, Partner , Mighty Capital | Wade Bitaraf, Founder, Energy & Sustainability, Plug & Play Tech Center | Greg Bohlen, Managing Director, Union Grove Venture Partners | Peter Bruce-Clark, Partner, Social Impact Capital | Darren Cooke, Investor, Life Science Angels | Ross Darwin, Principal, Owl Ventures | Anne DeGheest, Founder, HealthTech Capital | Jun Deng, Partner, Joyance Partners | Robert Dunkle, President, ABES Venture Partners | Anna Fokina, Senior Associate, Data Collective | Norm Gitis, Managing Partner, Lymo Ventures | Sheeraz Haji, Managing Partner, Zip Dragon Ventures | Charlie Hanna, Investor, Marcy Venture Partners | Daniel Harris, Managing Director, DPH Ventures | Guy Horowitz, Partner, Deutsche Telekom Capital Partners | Jens Horstmann, Founding Director, Crestlight Ventures | Najib Khouri-Haddad, General Partner, Sway Ventures | Howard Ko, Principal, Morpheus Ventures | Elaine Kunda, Founder & Managing Director, Disruption Ventures | Ricky Lai, Principal, Portag3 Ventures | Anh Le, Partner, CRCM Ventures | James Lee, Investment Associate Director, Photon Fund | Darwin Ling, Founding General Partner, Good AI Capital | Melina Mathur, Principal, Asset Management Ventures | Manan Mehta, Founding Partner, Unshackled Ventures | SC Moatti, Managing Partner, Mighty Capital | Mark Mueller-Eberstein, Angel Investor, Alliance of Angels | Ivan Nikkhoo, Managing Partner, Navigate Ventures | Kira Noodleman, Principal, Bee Partners | Damien Petty, Principal, Morpheus Ventures | Patrick Pfeffer, Lead Investor, Juniper Networks | Bill Reichert, Managing Director, Garage Technology Ventures | Mario Ruiz, Investor, Paypal Ventures | Ernst Sack, Partner, Blue Bear Capital | Praveen Sahay, Managing Director, WAVE Equity Partners | Gayatri Sarkar, Managing Partner, Hype Capital VC Fund | Charles Sidman, Managing Partner, ECS Capital Partners | Ratan Singh, Principal, Fort Ross Ventures | Li Sun, Partner, Foundation Capital | Erica Van, Investor, Charles River Ventures | Kutral Veerabadran, Principal, Flow Capital | Sonali Vijayavargiya, Managing Director, Augment Ventures | Elaine Zelby, Principal & Director of Growth, SignalFire | Stephanie Zepeda, Senior Associate, Arbor Ventures | Yanan Zhao, General Partner, Magnet Ventures | Sebastian Zhou, Investor, Alpha Square Group | Simin Zhou, VP & Managing Director, UL Ventures and many more.

 

 

Special Offer:

LPBI has made special arrangement for our network to receive a special discount of $450 off. This conference will be attended by the best people in the industry. Please register early to avoid disappointment. 

 

Register Today & Save Click here.   (Use promo code “ LPBI-VIP”)

 

In addition to providing access to leading Investors, the conference will feature more than 100 pre-screened venture backed, emerging and early stage companies seeking capital, and hardcore networking. 

 

 

Call for TOP INNOVATORS!

Get Noticed > Get Funded > Grow Faster

 

A select group of more than 100 Top Innovators will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners.

 

Apply to Present / Nominate a company:

For more information or to be considered for one of the Top Innovator slots click here.

 

Seed Pitchfest:

If you are a seed stage company seeking angel funding of less than $1M (and have raised less than $300,000) click here to apply for the Seed stage track.

 

 We look forward to seeing you there. 

 

LPBI & youngStartup Ventures

 

 @@@@@@

Leaders in Pharmaceutical Business Intelligence (LPBI ) Group is pleased to announce its sponsorship and invite you to join us at Venture Summit | West

Special offer:  Register Now & Save $450 off

(Use discount code “LPBI-VIP”)

* Call for Top Innovators Details below

Venture Summit | West

Where Innovation Meets Capital

March 23rd & 24th  2020

Santa Clara Convention Center, Silicon Valley

  

Come meet, interact and network with more than 1,300 VCs, Corporate VCs, angel investors, industry execs and founders of venture backed, emerging and early stage companies at the prestigious Venture Summit | West being held on March 23rd & 24th 2019 at the Santa Clara Convention Center. This year will again feature a dedicated Lifesciences/Healthcare Track.

 

Whether you’re a Lifesciences/Healthcare startup seeking capital and exposure, or an investor seeking new deals, Venture Summit West presented by youngStartup Ventures – is the event of the year you won’t want to miss.

 

A highly productive venture conference, Venture Summit | West is dedicated to showcasing VCs, Corporate VCs and angel investors committed to funding venture backed, emerging and early stage companies.

 

Lineup of over 150 VCs and Angels that spoke and judged at VSW19 includes:

Ben Abadi, Managing Director, Energy Innovation Capital | Navid Alipour, Co-founder and Managing Partner, Analytics Ventures | Logan Allin, General Partner & Founder, Fin Venture Capital | Kareem Aly, Principal, Thomvest Ventures | Magdi Amin, Investment Partner, Omidyar Network | Ash Archibald, Deal Principal, Wharton Angels | Jennifer Azapian, Partner , Mighty Capital | Carlos S. Baradello, General Partner, Alaya Capital Partners | Scott Beechuk, Partner, Norwest Venture Partners | Marcus Behrendt, Partner, BMW i Ventures | Lisha Bell, Dealflow Lead, Pipeline Angels | Ashish Bhatia, Angel Investor | Sunny Bia, Associate, CRCM Ventures | Mike Biddle, Managing Director, Evok Innovations | Alexa Binns, Associate, Maven Ventures | Wade Bitaraf, Founder, Energy & Sustainability, Plug & Play Tech Center | Tico Blumenthal, Co-chair of the Medical Device Screening Committee, Life Science Angels | Greg Bohlen, Managing Director, Union Grove Venture Partners | Will Borthwick, Senior Associate, Bold Capital Partners | Eric Breese, Investment Manager, Evonik Venture Capital | Maxx Bricklin, Founding Principal, Bold Capital Partners | Pratik Budhdev, Investment Director, Volvo Cars Tech Fund | Edouard Bulteau, Investment Manager, Total Energy Ventures | Andy Cao, Principal, Comcast Ventures | Packey Carrier, Investment Manager, American Express Ventures | Jeffrey Carter, General Partner, West Loop Ventures | Matthew Chavez, Associate, New Enterprise Associates | Joy Chen, Chief Investment Officer, TAL Education Group | Kelly Chen, Principal, Data Collective | Keting Chu, Venture Partner, LYFE Capital | Jackson Cummings, Investor, Salesforce Ventures | Michael D’Aurizio, Investment Manager, Centrica Innovations | Ned Daoro, Senior Associate, Clocktower Technology Ventures | Angelo Del Priore, Partner, HP Tech Ventures | Jun Deng, Partner, Joyance Partners | Dan Doble, Managing Director, SABIC Ventures | Rexhi Dollaku, Principal, Base10 | Yizhen Dong, Principal, 11.2 Capital | Ted Driscoll, Managing Partner, DigitalDX Ventures | Marah Dudenhoeffer, Manager, Verizon Ventures | Susannah Duke, Associate, Pelion Venture Partners | Robert Dunkle, President, ABES Venture Partners | Victor Echevarria, Principal, Jackson Square Ventures | Tom Eggleston, Managing Director , Charmides Capital | Geoffrey Eisenberg, Principal, Ecosystem Integrity Fund | Sean Engel, Principal, Top Tier Capital Partners | Michael Fanfant, Senior Associate, Runa Capital | Chenoa Farnsworth, Managing Director, Blue Startups | Kristen Faulkner, Associate, Threshold Ventures | Linda Fingerle, Partner, Tappan Hill Ventures | Spencer Foust, Principal, Sozo Ventures | Ben Freeberg, Senior Associate, Alpha Venture Partners | Chris Gaertner, Principal, Omega Venture Partners | Karim Gillani, General Partner, Luge Capital | Norm Gitis, Managing Partner, Life Science Angels | Garrett Goldberg, Partner, Bee Partners | Jocelyn Goldfein, Managing Director, Zetta Venture Partners | Daniel Gomez, Investment Analyst, Fusion Fund | Tyler Griffin, Managing Partner, Financial Venture Studio | Baris Guzel, Principal, BMW i Ventures | Perry Ha, Analyst, The Westly Group | Sheeraz Haji, Managing Partner, Zip Dragon Ventures | Daniel Harris, Managing Director, DPH Ventures | Laurence Hayward, Partner, Independence Equity | Annie Hazlehurst, Founder, Faridan | Alicia Castillo Holley, Investor, Sand Hill Angels | Jens Horstmann, Founding Director, Crestlight Ventures | Heyu Huang, Venture Partner, Fresco Capital | Anup Jacob, Co-Founder & Managing Director, Activate Capital Partners | Alexis Ji, Partner, Illumina Ventures | Gary Jinks, Founding Managing Director, South Valley Angels | Matt Jones, Managing Director, Solvay Ventures | Kathleen Jurman, Corporate Technology Scout, Dow Ventures | Amir Kabir, Investment Principal, Munich Re Ventures | Jimmy Kan, Senior Associate, Anzu Partners | Kester Keating, Head of US Strategic Investments, Barclays | Roger King, Founder, Bay Angels | Steve Kishi, Managing Director, Hummer Winblad Venture Partners | Yasemin Kliman, Co-President, Harvard Business School Angels | Daniella Kranjac, Co-Founder & Managing Director, Dynamk Capital | Nathan Krishnamurthy, Principal, Capital One Growth Ventures | Vivek Krishnamurthy, Associate, Commerce Ventures | Amit Kumar, Investor, Band of Angels | Kwasi Kyei, Associate, Sandbox Industries | Eduardo Laiter, Sr Investment Analyst, Kapor Capital | Severine Lalande, Investment Manager, Total Energy Ventures | Javaughn Lawrence, Investor, Eniac Ventures | Lindsay Lee, Managing Director, Authentic Ventures | Roberta Lee, Angel Investor, Life Science Angels | Sarah Lee, Investor, EdVentures Group | Julie Lein, Managing Partner, Urban Innovation Fund | Geraldine Le Meur, Founding Partner, The Refiners | Ephraim Lindenbaum, Managing Director, Advance Ventures | Alex Luce, Principal, Creative Ventures | Vincent Lui, Senior Director of Corporate Ventures, SK Telecom Americas | Silvia Mah, Executive Director and Founder, Hera Angels | Ashish Mahashabde, Investor, Amex Ventures | Shripriya Mahesh, Co-Founding Partner, Spero Ventures | Tasneem Manjra, Head of Network Development, Volvo Cars Tech Fund | Jillian Manus, Managing Partner, Structure Capital | Ben Metcalfe, Principal, Ridge Ventures | Wouter Meuleman, Director of Investments, Illumina Ventures | SC Moatti, Managing Partner, Mighty Capital | Linda Molnar, Program Director, National Science Foundation | Sasha Ostojic, Angel investor, Playground Global | Umesh Padval, Venture Partner, Thomvest Ventures | Hirak Parikh, Venture Partner, Augment Ventures | Victor Pascucci III, Managing Partner, Lightbank | Phoebe Peronto, Investor, Salesforce Ventures | Ricardo Politi, Partner, Mindset Ventures | Salil Pradhan, Venture Partner, Draper Nexus | Gagan Rana, Executive-in-Residence, Learn Capital | Peter Redford, Investor, Band of Angels | Bill Reichert, Managing Director, Garage Technology Ventures | John Ricci, Founder & Managing Partner, US Angels | Jennifer Richard, Senior Associate, Cross Culture Ventures | Andre Rocha, Investor, Glasswing Ventures | Riley Rodgers, Associate, Valia Investments | Peter Rojas, Founding Partner, Betaworks Ventures | Praveen Sahay, Managing Director, WAVE Equity Partners | Natalie Sandman, Senior Associate, Shasta Ventures | Miraj Sanghvi, Principal, DigiTx | Jason Schoettler, Co-Founder & Partner, Calibrate Ventures | Wes Selke, Managing Director, Better Ventures | Jayni Shah, Principal, Accomplice | Prashant Shah, Partner, Monta Vista Capita | Ann Shin, Founding Partner, Ultrafund Capital | Charles Sidman, Managing Partner, ECS Capital Partners | Kathleen Siswanto, Investor, Propel Venture Partners | Ira Smith, Director of Venture Investments, Pandect BioVentures | Tanya Soman, Venture Partner, 500 Startups | Shirley Speakman, Partner, Cycle Capital Management | Adam Spector, Angel Investor | Kumar Sripadam, Chair, TiE Global | Jack Statza, Senior Associate, Allstate Strategic Ventures | George Straschnov, Managing Director, Bisk Ventures | Marcus Stroud, Managing Partner, TXV Partners | Mayra Tama, Principal, Initial Capital | Wei Tao, Life Science Angels, Chair Bio Genomics Committee | Craig Taylor, General Partner, Alloy Ventures | Laura Thompson, Principal, Sapphire Ventures | Vishal Verma, General Partner, Edgewood Ventures | Che Voigt, Chairman, North Bay Angels | Jordan Wahbeh, Managing Director, Bay Angels | Timothy Wang, Principal, The Westly Group | Kyoko Watanabe, Managing Director, DEFTA Partners | Patricia Wexler, Co-Founder & Managing Director, Starlight Ventures | James Wu, Senior Associate, M12 | Jonathan Wu, Board Director and Vice President, Sand Hill Angels | Margaret Wu, Investor, Georgian Partners | Veronica Wu, Managing Partner, Hone Capital | Wei Wu, Healthcare Investment Director, BOE Ventures | Matthew Wukasch, Managing Director, Charmides Capital | Wenz Xing, Associate, Bullpen Capital | Sue Xu, Managing Partner , Amino Capital | Lu Zhang, Founder & Managing Partner, Fusion Fund | Jimmy Zhu, Vice President, Citi Ventures | Shelley Zhuang, Founder and Managing Partner, 11.2 Capital | TX Zhuo, Managing Partner, Fika Ventures and many more.

 

 

Special Offer:

LPBI has made special arrangement for our network to receive a special discount of $450 off.

This conference will be attended by the best people in the industry. Please register early to avoid disappointment. 

 

Register Today & Save Click here.   (Use promo code “ LPBI-VIP”)

 

In addition to providing access to leading Investors, the conference will feature more than 100 pre-screened venture backed, emerging and early stage companies seeking capital, and hardcore networking. 

 

Call for TOP INNOVATORS!

Get Noticed > Get Funded > Grow Faster

 

A select group of more than 100 Top Innovators will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners.

 

  • Apply to Present / Nominate a company:

For more information or to be considered for one of the Top Innovator slots click here.

 

  • Seed Pitchfest:

If you are a seed stage company seeking angel funding of less than $1M (and have raised less than $300,000) click here to apply for the Seed stage track.

 

 We look forward to seeing you there. 

 

LPBI & youngStartup Ventures

 

LPBI Group – Executive Summary

The Challenge

“Today, there is a digital information explosion in the fields of Life Sciences and Medicine,” said Aviva Lev-Ari, Ph.D., R.N., and founder of Leaders in Pharmaceutical Business Intelligence (LPBI) Group. “To manage that challenge, we are responding to the needs of our multi-faceted audiences in order to guard against information obsolescence through transformational technologies and solutions.”

 

Our Vision:

LPBI Group generates vast scientific content via industry thought leaders through multiple platforms and makes it universally accessible.

 

About LPBI Group

Leaders in Pharmaceutical Business Intelligence Group (“LPBI Group”) is a leading, electronic scientific content-creation venture, offering real-time, original scientific content through advanced platform architecture methodologies since 2012. The company’s commitment is to synthesize, analyze and interpret complex, medical and scientific disease information through electronic publishing venues via the cloud to advance the knowledge and research efforts of the scientific and business community.

LPBI Group was created in 2012 by Dr. Aviva Lev-Ari, Ph.D., R.N. The Group has evolved into three, interrelated domains – an open-access online scientific journal, a series of 16 BioMed e-books and real-time press coverage of BioMed scientific and medical conferences. Through this transformative offering, the Group effectively meets and exceeds the information needs of researchers, scientists and industry pharmaceutical and biotechnology executives by offering real-time and currently available medical and scientific information on any subject as well as cutting-edge biomedical research innovation widely available to the scientific and non-research community. The method of curation includes synthesis, analysis and interpretation of complex medical and scientific areas.

Year over year, there is increased readership of highly valued content, which equates to more than 5,500 scientific articles with over 1.6 million readers in the online scientific journal.

 

Unique, Experienced Team

The Group employs a team of highly experienced individuals in Life Sciences, particularly within the key domains of BioMedicine, Biotechnology, Pharmaco-therapy, Medical and Information Technology, Health Care and the Life Sciences/Medicine connection.

All members of the LPBI Group team have a wealth of expertise and experience in Life Sciences and have been trained to master the methodology of scientific curation used in the articles. Those individuals include senior MDs, MD/PhDs, PharmDs and senior PhDs who expressed interest in medical writing and clinical interpretation of basic research, translational research and interpretation of clinical trials outcomes.

  • Medical Doctors: Dr. Larry H. Bernstein (retired), Dr. Justin Pearlman (Central Maine Medical Center)
  • Doctors of Philosophy: Dr. Justin Pearlman, Dr. Stephen Williams, Dr. Sudipta Saha, Dr. Ritu Saxena, Dr. Tilda Barliya, Dr. Irina Robu, Dr. Dror Nir, Dr. Aviva Lev-Ari
  • Professors in Academia: Prof. Marcus W. Feldman (Stanford University), Prof. Stephen J. Williams (Temple University), Prof. Sudipta Saha (Amity University Noida, Uttar Pradesh, India), Dr. Irina Robu (Windsor, Ontario, Canada), Adam Sonnenberg, PhD(c), Boston University
  • Executives in Biotechnology and Information Technology Industries: Amnon Danzig, MBA, Europe-Asia (business development consultant with specialization in Strategy, Corporate Finance and Human Capital, published author on Value Creation concepts), Rick Mandahl, MBA, Americas (business development consultant in emerging technologies with Biotech, Information Technology focus), Ritu Saxena (Astellas Pharma), Gail S. Thornton, M.A., PhD(c), (Merck & Co., USA, communications consultant, published author on health, wellness, communications strategy)

 

Scientific e-Books Source

The 16 BioMed e-books include topics focused on medical science, diagnostics and therapy. The books’ sustainability is maintained by online continuing updates made to articles in the online scientific journal. Each of the scientific e-books contain an abbreviated electronic table of contents, which consists of ‘live’ links from each article in the e-book to the article in the online scientific journal. Readers of the e-books can click on this link to receive the most, updated “State of Science” for each topic. This unique feature makes the e-books relevant and provides a timely source of knowledge and reference.

Highly qualified content consultants, who are senior MDs, MD/PhDs and Professors, are involved in the production and clinical interpretations of the curations. The topics for curation and the contents of the books are uniquely created and carefully edited. Dr. Aviva Lev-Ari as the editor-in-chief leads this multidisciplinary content compilation using her diverse areas of technical training and experience. It should be noted that all of LPBI’s material could, in principle, be translated into other languages.

 

Journal Ontology

Our intellectual property consists of three classes of Intellectual property assets as described in detail with live links in the following article:

eScientific Publishing a Case in Point: Evolution of Platform Architecture Methodologies and of Intellectual Property Development (Content Creation by Curation) Business Model

https://pharmaceuticalintelligence.com/2019/02/04/escientific-publishing-a-case-in-point-evolution-of-platform-architecture-methodologies-and-of-intellectual-property-development-content-creation-by-curation-business-model/

 

Three Classes of Intellectual Property Assets

These assets include an open-access online scientific journal with curated, current biomedical research; a series of 16 BioMed e-books available via Amazon in five specialties of Medicine: Cardiovascular, Genomic Medicine (a subset of Precision Medicine), Cancer, Immunology and Precision Medicine; and real-time curation of biotech and medical conferences yielding an e-Proceedings at the end of the conference in one click operation.

For example, Genomic Medicine, as an emerging medical discipline, is making an impact in the fields of oncology, pharmacology, rare and undiagnosed diseases and infectious disease. This field involves using genomic information about an individual as part of their clinical care (e.g., for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use.

The open-access online scientific journal ontology is a relational and hierarchical knowledge base allowing for expansion of the content creation process between the journal and the series of BioMed e-books, but it is not limited to these two areas. For example, one of the research categories, entitled “Interviews with Scientific Leaders,” includes in its growth plan the option of podcasts, an audio media component that will supplement the video media component used extensively in the BioMed e-Series.

The Group’s business is scalable, and the skill set needed for curation of scientific findings for clinical interpretations, as well as in other disciplines can be augmented by appropriate training in the curation methodology to be offered to experts in many fields. In our seven years together, the Group’s writers and editors generated a remarkable synergy among experts, authors and writers, which yields outstanding collaboration in producing these curations. There are many post-doctoral individuals in the biotechnology industry as well as academia who can serve as experts, authors and writers in continuing the Group’s operations, following appropriate onboarding.

Contact us

Aviva Lev-Ari, PhD, RN

Director & Founder

https://lnkd.in/eEyn69r

Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston, NJ, Salt Lake City, Berkeley, Cambridge UK, Maine, New Delhi, Palo Alto, Philadelphia, Toronto

Editor-in-Chief

http://pharmaceuticalintelligence.com

e-Mail: avivalev-ari@alum.berkeley.edu

(M) 617-775-0451

https://cal.berkeley.edu/AvivaLev-Ari,PhD,RN

SkypeID: HarpPlayer83          LinkedIn Profile        Twitter Profile

Read Full Post »


Leaders in Pharmaceutical Business Intelligence (LPBI) Group

 

is pleased to announce its sponsorship and invite you to attend

The New England Venture Summit presented by youngStartup Ventures.

@pharma_BI

@AVIVA1950

 #NEVS

Agenda

●●●

Wednesday, December 4th, 2019

8:00 am

CONFERENCE REGISTRATION & CONTINENTAL BREAKFAST

8:50 am

WELCOME REMARKS

9:00 am

THE CHANGING VENTURE WORLD: WHAT CAN WE EXPECT FOR THE NEXT 24 MONTHS?

Venture Capital thought leaders debate the challenges and opportunities facing Investors and Entrepreneurs

Location: Fairbanks Ballroom

9:50 am

BREAK

10:00 am

COMPANY PRESENTATIONS – ROUND I

Track I:   Technology (Charles W. Fairbanks Ballroom)
Track II:  Life Sciences/Healthcare (Grace Ballroom)
Track III: Cleantech (New England Suite)
Track IV: Fintech (Westwood Suite)
Track V:  Seed Pitchfest (Erastus C. Fairbanks Ballroom)

11:00 am

NETWORKING & REFRESHMENT BREAK

11:40 am

COMPANY PRESENTATIONS – ROUND II

Track I:   Technology (Charles W. Fairbanks Ballroom)
Track II:  Life Sciences/Healthcare (Grace Ballroom)
Track III: Cleantech (New England Suite)
Track IV: Fintech (Westwood Suite)
Track V:  Seed Pitchfest (Erastus C. Fairbanks Ballroom)

12:50 pm

LUNCH & NETWORKING (12:50pm – 1:50pm)

Please see below for information on concurrent session running throughout lunch.

1:00 pm

RAISING ANGEL MONEY – INFO & INSIGHTS FROM SEASONED INVESTORS

Location: Grace Ballroom

1:50 pm

COMPANY PRESENTATIONS – ROUND III

Track I:   Technology (Charles W. Fairbanks Ballroom)
Track II:  Life Sciences/Healthcare (Grace Ballroom)
Track III: Cleantech (New England Suite)
Track IV: Fintech (Westwood Suite)
Track V:  Seed Pitchfest (Erastus C. Fairbanks Ballroom)

3:00 pm

CONCURRENT PANELS:

THE ART OF NEGOTIATING TERMS SHEETS

Entrepreneurs who don’t prepare well for term-sheet negotiations may find themselves locked into an uncomfortable relationship with their VC for years to come.  Whether you’re looking for a first-round or follow-up funding, attend this panel to learn what you should know about negotiating term sheets.

Location: Fairbanks Ballroom

ENERGIZING THE FLOW OF CLEAN-TECH DEALS

This session will discuss the trends in the financial markets and the future of venture capital investment in clean-tech.

Location: Grace Ballroom

BANKING ON FIN-TECH INNOVATION

Join top-tier VCs to discuss the rise of fintech, the integration of groundbreaking technologies within financial services, and the future of digital finance.

Location: New England Suite

3:50 pm

NETWORKING & REFRESHMENT BREAK

4:30 pm

CONCURRENT PANELS:

FUNDABLE DEALS: MAKING VCs SIT UP AND TAKE NOTICE

Ideas are all well and good, but in order to attract capital they will need to be packaged and presented in a way that will entice investors and of course a SOLID business model.  This panel will discuss the skills required to make a highly effective pitch that will attract potential financiers and the types of deals investors want.

Location: Grace Ballroom

 

CORPORATE VENTURE CAPITAL: WHAT YOU NEED TO KNOW

With a new flowering of startup innovation, many giants of industry have decided to enter or re-enter the world of VC. This session will explore the value-added investment approach of Corporate VCs and how it yields important dividends that are “beyond the bottom line,” both for the investor and for the startup.

Location: Fairbanks Ballroom

LIFE SCIENCES & HEALTHCARE VC CHECKUP

VCs compare and contrast the growth of seemingly healthy companies. What did these companies do right? Where did they go wrong? Which one would be considered a healthier investment and why? Does your company measure up? What healthy habits will make your company a more desirable investment? Find out if you pass the VC health checkup.

Location: New England Suite

5:20 pm

AWARDS & CLOSING REMARKS

5:30 pm

SUMMIT ADJOURNS

UPDATED on 11/25/2019

 

Last chance to register for The New England Venture Summit presented by youngStartup Ventures.

Special discount.  Use discount code LPBI-VIP” and receive $100 off the current rates

 

>> Call for Top Innovators to present to leading Investors (details below).

 

New England

Venture Summit

December 4th 2019 | Hilton | Boston, Dedham

 

Where Innovation Meets Capital

 

 

Friends,

 

Come meet, interact and network with hundreds of VCs, Corporate VCs, angel investors, investment bankers and founders of venture backed, emerging and early stage companies on the Lifesciences/Healthcare Track at the prestigious New England Venture Summit being held on December 4th 2019 at the Hilton in Boston, Dedham.

 

Whether you’re a Lifescience/Healthcare startup seeking capital and exposure, or a Biotech investor seeking new deals, The New England Venture Summit presented by youngStartup Ventures – is the event of the year you won’t want to miss.

 

A highly productive venture conference, the Lifesciences/Healthcare track at The New England Venture Summit is dedicated to showcasing VCs, Corporate VCs and angel investors committed to funding venture backed, emerging and early stage companies.

 

Partial List of over 150 VCs & Angel Investors confirmed to speak and judge includes:Anil Achyuta, Investment Director, TDK Ventures | Omair Ahmed, Associate, Echo Health Ventures | Navneet Alag, Vice President, H.I.G. BioHealth Partners | Dave Anderson, Managing General Partner, Supply Chain Ventures | Mark Austin, Managing Director, Viridian Capital | Shannon Austin, Partner, Financial Venture Studio | Natalie Bartlett, Investor, General Catalyst | Anna Batarina, Partner, Apple Tree Partners | Kyle Beatty, Principal, American Family Ventures | Anthony Bellafiore, Associate, LaunchCapital | Ned Berman, Senior Associate, Samsung Catalyst Fund | Matt Bloom, Investment Director, Connecticut Innovations | Carsten Boers, Managing Partner, Rhapsody Venture Partners | Greg Bohlen, Managing Director, Union Grove Venture Partners | Caitlin Bolnick, Investor, OpenView Venture Partners | Lee Bouyea, Managing Director, Fresh Tracks Capital | Maureen Boyce, Managing Partner, Good Growth Capital | Eric Breese, Investment Manager, Evonik Venture Capital | Nathaniel Brinn, Partner, VC23 Investors | Brendan Brits, Investor, Bertelsmann Digital Media Investments | Peter Bruce-Clark, Partner, Social Impact Capital | Ciara Burnham, Partner, QED Investors | Daniel Burstein, Managing Partner, Millennium Technology Value Partners | Jeffrey Carter, General Partner, West Loop Ventures | Kathryn Cartini, Partner, Chloe Capital | Anup Chamrajnagar, Investor, Point72 Ventures | Sean Cheng, Investment Manager, Philips Ventures | Ian Chiang, Principal, Flare Capital Partners | Elizabeth Cho-Fertikh, Co-Founder & Managing Director, MEDA Angels | Andrew Clapp, Managing Director, CIG CAP | Iain Cooper, Manager Corporate Ventures, Schlumberger Technology Investments | Mark Cupta, Partner, Prelude Ventures | John Curtin, Associate, Waterline Ventures | Kapil Desai, Vice President, Catalyst Investors | Damien Despinoy, Director, Energy Foundry | Dan Doble, Managing Director, SABIC Ventures | Lisa Dolan, Principal, Link Ventures | Tyler Durham, Principal, Schlumberger Technology Investments | Laura Easton, Analyst, Real Ventures | Jonathan Friedlander, Principal, Digitalis Ventures | Lisa Frusztajer, Lead Investor, Portfolia Enterprise Fund | Ernestine Fu, Venture Partner, Alsop Louie Partners | Stan Fung, Managing Director, FarSight Ventures | Robert Garber, Partner, 7wire Ventures | Stephen Gilfus, Founder, Blackboard Inc. | Elianna Goldstein, Analyst, Boeing HorizonX Ventures | Alex Golod, Angel Investor, Chicago ArchAngels | Emilia Gonzalez, Principal, Joyance Ventures | Michelle Gouveia, Associate, Sandbox Insurtech Ventures | Edward Greer, Corporate Technology Scout, Dow Ventures | Vicky Guo, Investment Director, Pearson Ventures | Robert Hamlin, Principal, Portag3 Ventures | Jana Hanova, Director, Evok Innovations | Sven Harmsen, Director External Ventures, NOVA External Ventures Saint-Gobain | Andrew Hartford, Managing Partner, Hartford Lab | Martin Heidecker, Director, Investment Manager, Boehringer Ingelheim Venture Fund | Kaitlyn Henry, Associate, OpenView Venture Partners | Chris Ho, Vice President, Vickers Venture Partners | Toan Huynh, Partner, Information Venture Partners | Ben Jen, CEO & Angel Investor, Ben Jen Holdings LLC | Del Johnson, Principal, Backstage Capital | Jay Karandikar, Venture Partner, New Crop Capital | Madeline Keulen, Vice President, Victress Capital | Roman Kikta, Managing Partner & Founder, Mobility Ventures | Frank Klemens, Managing Director, DuPont Ventures | Jak Knowles, Vice President Venture Investments, Leaps by Bayer | Diana Kontsevaia, Investor, Dell Technologies Capital | Ventures | Luda Kopeikina, Investment Director, DSM Venturing | Elaine Kunda, Founder & Managing Director, Disruption Ventures | Ed Lafferty, Partner & CFO, Saturn Partners | Logan Langberg, Principal, Imaginary Ventures | Tiffany Le, Investor, Kaiser Permanente Ventures | James Lee, Investment Associate Director, Photon Fund | Claire Leurent, Managing Director, Samsung Ventures | Debbie Lin, Executive Director & Investment Manager, Boehringer Ingelheim Venture Fund | Darwin Ling, Founding General Partner, Good AI Capital | Jim Lockheed, Investment Associate, JetBlue Technology Ventures | Mary Long-Irwin, Executive Director, Northern Ontario Angels | Bion Ludwig, Partner, Savano Capital Partners | Josh Lumer, Senior Associate, Allstate Strategic Ventures | Alan MacIntosh, General Partner, Real Ventures | Wasim Malik, Managing Partner, Iaso Ventures | Ricky Margolis, VP of Business Development, ARIE Capital | Hollis McGuire, Director, Impact NH Fund | Theo Mendez, Investor, Insight Partners | Philip Mertens, Investment Analyst, DSM Venturing | Sarah Millar, Associate, City Light Capital | David Miller, Co-Founder and Managing Director, Clean Energy Ventures | Mark Miller, Managing Partner, Good Harbor Partners | Yiannis Monovoukas, Co-Founder & Managing Partner, SpringTide Ventures | Craig Mullett, Director, Angel Investor Forum | Jared Newman, Associate, Betawork Ventures | Clay Norris, Investment Associate, Carolinas Fintech Ventures | Michael Pachos, Head of East Coast / Managing Director, Samsung Ventures | Akhilesh Pathipati, Principal, MVM Partners | Charles Paul, Vice President – Technology, Henkel Ventures | Caroline Pelletier, Angel Investor, Anges Québec | Mike Perry, Investment Associate, Link Ventures | Damien Petty, Principal, Morpheus Ventures | Lauren Michelle Pfeifer, Principal, Maschmeyer Group Ventures | Benjamin Price, Venture Manager, NOVA External Ventures Saint-Gobain | Suraj Kumar Rajwani, Co-Founder and Partner, DoubleRock Venture Capital | Ashley Ramirez, Investor & Chief of Staff, Halogen Ventures | Jeff Ransdell, General Partner, Rokk3r Fuel ExO | Wanda Reindorf, Managing Director, Clean Energy Venture Group | Alison Andrews Reyes, General Partner, 1843 Capital | Lisa Rhoads, Managing Director, Easton Capital Investment Group | Candace Richardson, Senior Associate, Town Hall Ventures | Mark Robinson, Founder and Managing Director, WAVE Equity Partners | Gus Roman, Venture Capital Associate, Global Founders Capital | Rob Rosenberg, Partner, Prolog Ventures | Brita Rosenheim, Partner, Better Food Ventures | Robert Rothman, Founder and Managing Member, InFocus Capital Partners | Tayo Sanders, Associate, Anzu Partners | Sugam Sarin, Investment Manager, American Express Ventures | Jennifer Schretter, Partner, PROOF VC | Brian Schuman, Associate Manager, PepsiCo Technology Ventures | Paul Seidler, Managing Director, Clean Energy Trust | Shantnu Sharma, Managing Director, AMD Ventures | Charles Sidman, Managing Partner, ECS Capital Partners | Jean Sini, Angel Investor | Matt Snow, Analyst, Greenspring Associates | Vivek Soni, Venture Partner, S Cap Cleantech Fund | Adarsh Sowcar, External Ventures Manager, NOVA External Ventures Saint-Gobain | Joseph Spivack, Angel Investor | Lindsay Karas Stencel, Managing Partner, Gravity Ventures | Lutz Stoeber, Investment Director, Evonik Venture Capital | Neil Swami, Principal, Catalyst Health Ventures | Byron Thom, Principal, Framework Venture Partners | Michael Thomas, Investment Director, Inova Health System Strategic Investments | Alexander Urban, Associate, Shell Ventures | Claude Vachet, Managing Partner, Cycle Capital Management | Erica Van, Investor, Charles River Ventures | Kutral Veerabadran, Principal, Flow Capital | Sonali Vijayavargiya, Managing Director, Augment Ventures | Patrick Walsh, Director, National Grid Partners | George Wang, Associate, Global Founders Capital | Raymond Wang, Investor, Two Sigma Ventures | John Wei, Senior Investment Manager, SABIC Ventures | Jeffrey Weiss, Senior Venture Partner, Clean Energy Ventures | Catherine Friend White, Managing Director, Golden Seeds | Henry White, Venture Partner, Good Growth Capital | Alex Whitney, Senior Analyst, ManchesterStory Group | Jacqueline Wibowo, Investor, Insight Partners | Tom Wisniewski, Co-Founder & Managing Partner, Newark Venture Partners | Joanne Wong, General Partner, REDDS Capital | Zac Yu, Investor, Magnet Ventures | Greg Zaic, Principal and General Partner, NMT Capital | Lu Zhang, Founder & Managing Partner, Fusion Fund | Sebastian Zhou, Investor, Alpha Square Group | Chris Zock, Managing Director, Sandbox Insurtech Ventures and many more…

 

Special Offer:

Leaders in Pharmaceutical Business Intelligence has made special arrangement for our network to receive $100 off the current rates.

This conference will be attended by the best people in the industry. Please register asap to avoid disappointment. 

 

Register Today & Save Click here.   (Use promo code “LPBI-VIP”)

 

In addition to providing access to leading Investors, the conference will feature more than 100 pre-screened venture backed, emerging and early stage companies seeking capital, and hardcore networking.

 

 

Call for TOP INNOVATORS!

Get Noticed > Get Funded > Grow Faster

 

A select group of more than 150 Top Innovators will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners.

 

Apply to Present / Nominate a company:

For more information or to be considered for one of the Top Innovator slots click here.

 

Seed Pitchfest:

If you are a seed stage company seeking angel funding of less than $1M (and have raised less than $300,000) click here to apply for the Seed stage track.

 

We look forward to seeing you there. 

 

Leaders in Pharmaceutical Business Intelligence & youngStartup Ventures

@@@@@

Special discount offered   

Use discount code LPBI-VIP and receive 10% off the “early bird” rates.

 

Call for Top Innovators to present to leading Investors (details below).

 

New England Venture Summit

December 3rd & 4th 2019 | Hilton | Boston, Dedham

Where Innovation Meets Capital

 

 http://bit.ly/2M8rxzd

UPDATES

From: “Gil Garalnick [FinTrack Venture Summit]” <Gil@youngstartup.com>

Date: Monday, October 7, 2019 at 3:45 PM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: RE: Industry Partnership Update: New England Venture Summit

 

Hi Aviva –

 

Pleased to share an updated list of over 100 VCs and Angels confirmed to speak.

 

Early bird rates end October 31st. Would it feasible to share an update with your network? I can send over updated copy.

 

Partial List of over 100 VCs & Angel Investors confirmed to speak and judge includes:

Anil Achyuta, Investment Director, TDK Ventures | Omair Ahmed, Associate, Echo Health Ventures | Mark Austin, Managing Director, Viridian Capital | Natalie Bartlett, Investor, General Catalyst | Ned Berman, Senior Associate, Samsung Catalyst Fund | Carsten Boers, Managing Partner, Rhapsody Venture Partners | Greg Bohlen, Managing Director, Union Grove Venture Partners | Caitlin Bolnick, Investor, OpenView Venture Partners | Eric Breese, Investment Manager, Evonik Venture Capital | Brendan Brits, Investor, Bertelsmann Digital Media Investments | Ciara Burnham, Partner, QED Investors | Daniel Burstein, Managing Partner, Millennium Technology Value Partners | Jeffrey Carter, General Partner, West Loop Ventures | Kathryn Cartini, Partner, Chloe Capital | Anup Chamrajnagar, Investor, Point72 Ventures | Sean Cheng, Investment Manager, Philips Ventures | Elizabeth Cho-Fertikh, Co-Founder & Managing Director, MEDA Angels | Andrew Clapp, Managing Director, CIG CAP | Iain Cooper, Manager Corporate Ventures, Schlumberger Technology Investments | Mark Cupta, Partner, Prelude Ventures | Kapil Desai, Vice President, Catalyst Investors | Damien Despinoy, Director, Energy Foundry | Dan Doble, Managing Director, SABIC Ventures | Jesse Draper, Founding Partner, Halogen Ventures | Tyler Durham, Principal, Schlumberger Technology Investments | Laura Easton, Analyst, Real Ventures | Jonathan Friedlander, Principal, Digitalis Ventures | Lisa Frusztajer, Lead Investor, Portfolia Enterprise Fund | Stan Fung, Managing Director, FarSight Ventures | Robert Garber, Partner, 7wire Ventures | Stephen Gilfus, Founder, Blackboard Inc. | Emilia Gonzalez, Principal, Joyance Ventures | Ajay Gopal, Founding Principal, Framework Venture Partners | Michelle Gouveia, Associate, Sandbox Insurtech Ventures | Edward Greer, Corporate Technology Scout, Dow Ventures | Vicky Guo, Investment Director, Pearson Ventures | Brooke Hammer, Associate, F-Prime Capital | Jana Hanova, Director, Evok Innovations | Andrew Hartford, Managing Partner, Hartford Lab | Martin Heidecker, Director, Investment Manager, Boehringer Ingelheim Venture Fund | Kaitlyn Henry, Associate, OpenView Venture Partners | Jay Karandikar, Venture Partner, New Crop Capital | Madeline Keulen, Vice President, Victress Capital | Roman Kikta, Managing Partner & Founder, Mobility Ventures | Frank Klemens, Managing Director, DuPont Ventures | Diana Kontsevaia, Investor, Dell Technologies Capital | Ventures | Luda Kopeikina, Investment Director, DSM Venturing | Elaine Kunda, Founder & Managing Director, Disruption Ventures | Logan Langberg, Principal, Imaginary Ventures | James Lee, Investment Associate Director, Photon Fund | Claire Leurent, Managing Director, Samsung Ventures | Darwin Ling, Founding General Partner, Good AI Capital | Jim Lockheed, Investment Associate, JetBlue Technology Ventures | Mary Long-Irwin, Executive Director, Northern Ontario Angels | Wasim Malik, Managing Partner, Iaso Ventures | Hollis McGuire, Director, Impact NH Fund | Sarah Millar, Associate, City Light Capital | Craig Mullett, Director, Angel Investor Forum | Jared Newman, Associate, Betawork Ventures | Clay Norris, Investment Associate, Carolinas Fintech Ventures | Mike Perry, Investment Associate, Link Ventures | Lauren Michelle Pfeifer, Principal, Maschmeyer Group Ventures | Jeff Ransdell, General Partner, Rokk3r Fuel ExO | Wanda Reindorf, Managing Director, Clean Energy Venture Group | Alison Andrews Reyes, General Partner, 1843 Capital | Lisa Rhoads, Managing Director, Easton Capital Investment Group | Mark Robinson, Founder and Managing Director, WAVE Equity Partners | Gus Roman, Venture Capital Associate, Global Founders Capital | Rob Rosenberg, Partner, Prolog Ventures | Tayo Sanders, Associate, Anzu Partners | Jennifer Schretter, Partner, PROOF VC | Reese Schroeder, Managing Director, Tyson Ventures | Paul Seidler, Managing Director, Clean Energy Trust | Shantnu Sharma, Managing Director, AMD Ventures | Jean Sini, Angel Investor | Vivek Soni, Venture Partner, S Cap Cleantech Fund | Joseph Spivack, Angel Investor | Alex Steiner, Investment Analyst, Anthemis Group | Lutz Stoeber, Investment Director, Evonik Venture Capital | Neil Swami, Principal, Catalyst Health Ventures | Alexander Urban, Associate, Shell Ventures | Claude Vachet, Managing Partner, Cycle Capital Management | Erica Van, Investor, Charles River Ventures | Patrick Walsh, Director, National Grid Partners | Raymond Wang, Investor, Two Sigma Ventures | Greg Zaic, Principal and General Partner, NMT Capital | Lu Zhang, Founder & Managing Partner, Fusion Fund | Sebastian Zhou, Investor, Alpha Square Group | Chris Zock, Managing Director, Sandbox Insurtech Ventures and many more…

 

Look forward to hearing from you.

 

 

Regards

 

Gil

 

Gil Garalnick

Associate 
youngStartup Ventures
“Where Innovation Meets Capital”

 

p: 212.202.1002

e: gil@youngstartup.com

u: www.youngstartup.com

 

Friends,

 

Come meet, interact and network with hundreds of VCs, Corporate VCs, angel investors, investment bankers and founders of venture backed, emerging and early stage companies on the Lifesciences/Healthcare Track at the prestigious New England Venture Summit being held on December 3rd & 4th 2019 at the Hilton in Boston, Dedham.

 

Whether you’re a Lifescience/Healthcare startup seeking capital and exposure, or a Biotech investor seeking new deals, The New England Venture Summit presented by youngStartup Ventures – is the event of the year you won’t want to miss.

 

A highly productive venture conference, the Lifesciences/Healthcare track at The New England Venture Summit is dedicated to showcasing VCs, Corporate VCs and angel investors committed to funding venture backed, emerging and early stage companies.

 UPDATED on 8/27/2019

 

VCs & Angel Investors confirmed to speak and judge includes:

Mark Austin, Managing Director, Viridian Capital | Greg Bohlen, Managing Director, Union Grove Venture Partners | Ciara Burnham, Partner, QED Investors | Jeffrey Carter, General Partner, West Loop Ventures | Kathryn Cartini, Partner, Chloe Capital | Anup Chamrajnagar, Investor, Point72 Ventures | Andrew Clapp, Managing Director, CIG CAP | Iain Cooper, Manager Corporate Ventures, Schlumberger Technology Investments | Jesse Draper, Founding Partner, Halogen Ventures | Tyler Durham, Principal, Schlumberger Technology Investments | Robert Garber, Partner, 7wire Ventures | Stephen Gilfus, Founder, Blackboard Inc. | Emilia Gonzalez, Principal, Joyance Ventures | Ajay Gopal, Founding Principal, Framework Venture Partners | Michelle Gouveia, Associate, Sandbox Insurtech Ventures | Martin Heidecker, Director, Investment Manager, Boehringer Ingelheim Venture Fund | Kaitlyn Henry, Associate, OpenView Venture Partners | Jay Karandikar, Venture Partner, New Crop Capital | Roman Kikta, Managing Partner & Founder, Mobility Ventures | Elaine Kunda, Founder & Managing Director, Disruption Ventures | Darwin Ling, Founding General Partner, Good AI Capital | Sarah Millar, Associate, City Light Capital | Craig Mullett, Director, Angel Investor Forum | Jared Newman, Associate, Betawork Ventures | Lauren Michelle Pfeifer, Principal, Maschmeyer Group Ventures | Lisa Rhoads, Managing Director, Easton Capital Investment Group | Mark Robinson, Founder and Managing Director, WAVE Equity Partners | Tayo Sanders, Associate, Anzu Partners | Reese Schroeder, Managing Director, Tyson Ventures | Paul Seidler, Managing Director, Clean Energy Trust | Jean Sini, Angel Investor | Vivek Soni, Venture Partner, S Cap Cleantech Fund | Alex Steiner, Investment Analyst, Anthemis Group | Claude Vachet, Managing Partner, Cycle Capital Management | Erica Van, Investor, Charles River Ventures | Raymond Wang, Investor, Two Sigma Ventures | Greg Zaic, Principal and General Partner, NMT Capital | Lu Zhang, Founder & Managing Partner, Fusion Fund | Chris Zock, Managing Director, Sandbox Insurtech Ventures and many more…

 

Lineup of over 120 VCs & Angels that spoke and judged at NEVS18 includes:

Karine Agajanian, Analyst, Anzu Ventures | Sanjay Aggarwal, Venture Partner, F-Prime Capital Partners | Magdi Amin, Investment Partner, Omidyar Network | Peter Arkell, Investor, Norwest Venture Partners | Mark Austin, Partner, Bright Capital | Salman Azhar, Managing Director, Duke Angel Network | Ibraheem Badejo, Sr. Director, Johnson & Johnson Innovation | Sunny Bai, Associate, CRCM Ventures | Janet Bannister, Partner, Real Ventures | Peter Bastien, Partner, Next47 | Alex Beletsky, Investor, Sidecar Angels | Woody Benson, Venture Partner, Launch Capital | Joshua Berg, Investment Manager, GM Ventures | Raghav Bhargava, Associate, NEA | Victor Bian, Associate, Intellectual Ventures | Laura Bock, Investor, QED Investors | Nabil Borhanu, Managing Partner, Graphene Ventures | Will Borthwick, Senior Associate, Bold Capital Partners | Lee Bouyea, Managing Director, FreshTracks Capital | Eric Breese, Managing Director, Evonik Venture Capital | Maxx Bricklin, Founding Principal, Bold Capital Partners | Dan Burstein, Managing Partner, Millennium Technology Value Partners | Jason Cahill, Founder & Managing Director, McCune Capital | Neil Callahan, Co-Founder and Managing Director, Pilot Growth Equity | Efayomi Carr, Associate, Quona Capital | Sara Chamberlain, Managing Director, Energy Foundry | Raymond Chang, Managing Director, NXT Ventures | Christopher Chu, Managing Director, Samsung Catalyst Fund | Meghan Cross Breeden, Managing Partner, Red Bear Angels | David Cruikshank, Partner, ARCH Venture Partners | Sophia Dardashti, Associate, WorldQuant Ventures | Ekaterina Dorozhkina, Managing Partner, Starta Ventures | Miriam Eaves, Venture Partner, BP Ventures | Kathryn Meng Elmes, Investment Associate, Massachusetts Clean Energy Center | Alison Ernst, Senior Manager of Investments, Massachusetts Clean Energy Center | Teresa Esser, Managing Director, Silicon Pastures | Michael Fanfant, Investor, Runa Capital | David Feldman, Analyst, Indicator Ventures | Mark G. Fields, Partner, Alsop Louie Partners | Shawn Flynn, Investment Director, Bay Angels | Prashant Fonseka, Principal, Tuesday Capital | Haley Fradkin, Investment Associate, Plum Alley | Lisa Frusztajer, Investor, Portfolia Enterprise Fund | Kyle Fugere, Head of Ventures, dunnhumby Ventures | Matt Gatto, Partner, Insight Venture Partners | Joy Ghosh, Investor, Bain Capital Ventures | Stephen Gilfus, Founder, Blackboard Inc. | Jamil Goheer, Managing Partner & Cofounder, CoVenture | Ben Gorman, Associate, F-Prime Capital Partners | Edward Greer, Corporate Technology Scout, Dow Ventures | Jacob E. Grose, Investment Manager, BASF Venture Capital | Zain Gulamali, Investor, Amazon Alexa Fund | Marina Hadjipateras, Co-Founder & General Partner, Trail Mix Ventures | Hunter Hartwell, Principal, Forte Ventures | Laurence Hayward, Founding Partner, Independence Equity | Nathaniel Henshaw, Managing Director, CEI Ventures | Michael Hoeksema, Associate, Battery Ventures | Lindsay Hyde, Venture Partner, Moderne Ventures | Oren Isacoff, Principal, Longitude Capital | Nicolas Jacques-Bouchard, Principal, Panache Ventures | Jamie James, Managing Partner, GreenSoil Building Innovation Fund | Noel Jee, Investor, Illumina Ventures | Lacey Johnson, Principal, Green D Ventures | Ajay Kamat, Managing Director, Pear Ventures | Alex Kaufman, Investment Associate, JetBlue Technology Ventures | Shane Kelly, Head of Investments, CrowdSmart | Patrick Kenealy, Managing Director, Ridge Ventures | Jack Kerrigan, Managing Director, Razor’s Edge Ventures | Jonathan Kerstein, Associate, Red Sea Ventures | Nyla Koncurat, Managing Partner, Karlani Capital | Daniel Kwak, Investor, Point72 Ventures | Vivek Ladsariya, Partner, SineWave Ventures | Donna Lecky, Managing Director, Health Venture Capital | Linus Liang, Senior Associate, Signia Venture Partners | Bion Ludwig, Partner, Savano Capital Partners | Kyle Lui, Principal, DCM Ventures | Tamim Abdul Majid, Principal, OCA Ventures | Nurzhas Makishev, Managing Partner, NKM Capital | Eller Mallchok, Managing Director, Jumpstart Foundry | Coppelia Marincovic, Investment Manager, Solvay Ventures | Olga Maslikhova, Managing Partner, Phystech Ventures | Tom Mastrobuoni, Chief Financial Officer, Tyson Ventures | Hiroki Matsuda, Investor, Sozo Ventures | Derek Mazur, Senior Associate, Sante Ventures | David Miller, Co-Founder and Managing Director, Clean Energy Ventures | Julia Moore, Partner, Breakout Ventures | Kirsten Morbeck, Managing Director, SpringRock Ventures | Amit Mulgaonkar, Investor, Mithril Capital Management | Sheila Narayan, Managing Director, Golden Seeds | David Nault, General Partner, Luge Capital | Sara M. Nayeem, Partner, NEA | Brian Panoff, Senior Principal, Shell Ventures | Sumay Parikh, Principal, Quake Capital | Daniel Povitsky, Vice President, Sinai Ventures | Vinny Pujji, Investor, Insight Venture Partners | Venu Raghavan, Vice President, Wasson Enterprise | Gopal Rajaraman, Investment Principal , Motorola Solutions Venture Capital | Wanda Reindorf, Managing Director, Clean Energy Ventures | Brendan Rempel, Associate, OpenView Venture Partners | Martin Ringlein, Venture Partner, NextGen Venture Partners | Praveen Sahay, Managing Director, WAVE Equity Partners | Louis Schick, Founding Partner, NewWorld Capital Group | Chris Seitz, Associate, Excel Venture Management | Connie Sheng, Founding Managing Partner, Nautilus Venture Partners | Alex Shtarkman, Associate, Revolution | John Simon, Managing Director, Sigma Prime Ventures | Sidarth Singh, Investor, Stripes Group | Emily Snyder, Associate, Borealis Ventures | Vivek Soni, Managing Director, TiE-Boston Angels | Siri Srinivas, Associate, Draper Associates | Luisa Sucre, Associate, Revolution | Lyndsey Toeppen, Vice President, Sandbox Insurtech Ventures | Tibor Toth, Managing Director, Massachusetts Clean Energy Center | Laurel Touby, Partner, Supernode Ventures | Chisom Uche, Associate, SixThirty | Alexander Urban, Principal, Shell Ventures | Claude Vachet, Managing Partner, Cycle Capital Management | Maria Velissaris, Investor, Pipeline Angels | Anthony Walsh, Principal, BioInnovation Capital | John Wei, Sr. Investment Manager, SABIC Ventures | Jamie M. Weston, Managing Director, Spring Mountain Capital | Christopher J. Whalen, Managing Director, New Technology Ventures | Thomas Whiteaker, Partner, Propel Venture Partners | Jillian Williams, Investor, Anthemis Group | Troy Williams, Managing Director, University Ventures | Lu Zhang, Founder & Managing Partner, Fusion Fund | Sanjay Zimmermann, Associate, White Star Capital and many more.

 

Special Offer:

Leaders in Pharmaceutical Business Intelligence (LPBI) Group has made special arrangement for our network to receive a special discount of 10% off the existing “early bird” savings.

This conference will be attended by the best people in the industry. Please register early to avoid disappointment. 

 

Register Today & Save Click here.   

(Use promo code “LPBI-VIP”)

 

In addition to providing access to leading Investors, the conference will feature more than 100 pre-screened venture backed, emerging and early stage companies seeking capital, and hardcore networking. 

 

 

Call for TOP INNOVATORS!

Get Noticed > Get Funded > Grow Faster

 

A select group of more than 100 Top Innovators from the Life Sciences/Healthcare sector will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners.

 

Apply to Present / Nominate a company:

For more information or to be considered for one of the Top Innovator slots click here.

 

Seed Pitchfest:

If you are a seed stage company seeking angel funding of less than $1M (and have raised less than $300,000) click here to apply for our Seed stage track.

 

We look forward to seeing you there. 

 

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

&

youngStartup Ventures

 

REAL TIME Press Coverage for

 http://pharmaceuticalintelligence.com 

by

 Aviva Lev-Ari, PhD, RN

Director & Founder, Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston

Editor-in-Chief, Open Access Online Scientific Journal, http://pharmaceuticalintelligence.com

Editor-in-Chief, BioMed e-Series, 16 Volumes in Medicine, https://pharmaceuticalintelligence.com/biomed-e-books/

@pharma_BI

@AVIVA1950

 #NEVS

 

Logo, Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston

Our BioMed e-series

WE ARE ON AMAZON.COM

https://lnkd.in/ekWGNqA

2019 New England Venture Summit, December 3rd & 4th 2019 at the Hilton in Boston, Dedham, MA, hosted by youngStartUp #NEVS

 

AGENDA

Wednesday, December 4th, 2019

8:00 am

CONFERENCE REGISTRATION & CONTINENTAL BREAKFAST

8:50 am

WELCOME REMARKS

9:00 am

THE CHANGING VENTURE WORLD: WHAT CAN WE EXPECT FOR THE NEXT 24 MONTHS?

Venture Capital thought leaders debate the challenges and opportunities facing Investors and Entrepreneurs

9:50 am

BREAK

10:00 am

COMPANY PRESENTATIONS – ROUND I

11:00 am

NETWORKING & REFRESHMENT BREAK

11:40 am

COMPANY PRESENTATIONS – ROUND II

12:50 pm

LUNCH & NETWORKING

1:00 pm

RAISING ANGEL MONEY – INFO & INSIGHTS FROM SEASONED INVESTORS

1:50 pm

COMPANY PRESENTATIONS – ROUND III

3:00 pm

FUNDABLE DEALS: MAKING VCs SIT UP AND TAKE NOTICE

Ideas are all well and good, but in order to attract capital they will need to be packaged and presented in a way that will entice investors and of course a SOLID business model.  This panel will discuss the skills required to make a highly effective pitch that will attract potential financiers and the types of deals investors want.

3:00 pm

ENERGIZING THE FLOW OF CLEAN-TECH DEALS

This session will discuss the trends in the financial markets and the future of venture capital investment in clean-tech.

3:00 pm

ABCs ON ED-TECH INNOVATION & FUNDING

Ed-tech Investors will take center stage to grade the Ed-tech sector and share insights on the trends they’re seeing.

3:50 pm

NETWORKING & REFRESHMENT BREAK

4:30 pm

THE ART OF NEGOTIATING TERMS SHEETS

Entrepreneurs who don’t prepare well for term-sheet negotiations may find themselves locked into an uncomfortable relationship with their VC for years to come.  Whether you’re looking for a first round or follow-up funding, attend this panel to learn what you should know about negotiating term sheets.

4:30 pm

CORPORATE VENTURE CAPITAL: WHAT YOU NEED TO KNOW

With a new flowering of startup innovation, many giants of industry have decided to enter or re-enter the world of VC. This session will explore the value-added investment approach of Corporate VCs and how it yields important dividends that are “beyond the bottom line,” both for the investor and for the startup.

5:20 pm

AWARDS & CLOSING REMARKS

5:30 pm

SUMMIT ADJOURNS

SPEAKERS

https://youngstartup.com/newengland2019/#speakers-sec

Read Full Post »


#NYVS19 #NewYorkVentureSummit July 9th – 10th, Where #innovation Meets #Capital #startups connect with over 150 #AwesomeVCs and #Angels. http://bit.ly/30E9ci5 $100 off with Discount Code: LPBIVIP

 

Special discount.  Use discount code “ LPBIVIP” and receive $100 off the current rates.

Registration closes July 3rd

 

Call for Top Lifesciences/Healthcare Innovators to present to leading Investors (details below).

 

New York

Venture Summit

July 9th & 10th 2019 | Convene | New York City

Where Innovation Meets Capital

Friends,

Leaders in Pharmaceutical Business Intelligence Group

&

youngStartup Ventures

 

 

Come meet, interact and network with hundreds of VCs, Corporate VCs, angel investors, investment bankers and founders of venture backed, emerging and early stage companies on the Dedicated Lifesciences/Healthcare Track at the prestigious New York Venture Summit being held on July 9th & 10th 2019 at Convene, New York City.

 

Whether you’re a Lifesciences/Healthcare  startup seeking capital and exposure, or an investor seeking new deals, The New York Venture Summit presented by youngStartup Ventures – is the event of the year you won’t want to miss.

 

A highly productive venture conference, The New York Venture Summit is dedicated to showcasing VCs, Corporate VCs and angel investors committed to funding venture backed, emerging and early stage Lifesciences/Healthcare companies.

 

Partial list of over 150 VCs and Angels confirmed to speak and judge includes:

Jenny Abramson, Founder & Managing Partner, Rethink Impact | Nick Adams, Managing Partner & Co-Founder, Differential Ventures | Karine Agajanian, Senior Analyst, Anzu Partners | Andrew Aldrich, Principal, American Family Ventures | Jay Amarasekera, Senior Technology Manager, SABIC Ventures | Mark Austin, Managing Director, Viridian Capital | Michael Baldwin, Senior Associate, Moderne Ventures | Natalie Bartlett, Investor, General Catalyst | Greg Bennett, Senior Associate, Kapor Capital | Liza Benson, Partner, Moderne Ventures | Lily Bernicker, Associate, Collaborative Fund | Eric Bielke, Investment Director, GE Ventures | Laura Bock, Investor, QED Investors | Eric Breese, Investment Manager, Evonik Venture Capital | Matt Brennan, Partner, General Catalyst Partners | Joel Brightfield, Principal, SixThirty | Ciara Burnham, Partner, QED Investors | Daniel Burstein, Managing Partner, Millennium Technology Value Partners | Don Burton, Founding & Managing Partner, LearnStart | Jason Cahill, Founder & Managing Director, Carbon Ventures | Alex Carusillo, Venture Associate, OCA Ventures | Ray Cheng, Partner, Millennium Technology Value Partners | Bryan Ciambella, Principal, B Capital Group | Benjamin Cukier, Founder, Centana Growth Partners | Soraya Darabi, General Partner, Trail Mix Ventures | Tyler Dean, Investor, Point72 Ventures | Parth Desai, Investor, Flare Capital Partners | Damien Despinoy, Director, Energy Foundry | Sohum Doshi, Associate, Argentum Group | Alan Du, Investor, Millennium Technology Value Partners | Tyler Durham, Principal, Schlumberger Ventures | Kenny Estes, Co-Founder & Partner, West Loop Ventures | Dave Fan, Principal, Alumni Ventures Group | Michael Fanfant, Senior Associate, Runa Capital | Matt Fates, Founder & General Partner, Pulse Ventures | Sana Fathima, Investment Manager, Lockheed Martin Ventures | Mark G. Fields, Partner, Alsop Louie Partners | Linda Fingerle, President and Managing Director, Tappan Hill Ventures | Lindsay Fitzgerald, Managing Director, American Express Ventures | Haley Fradkin, Investment Associate, Plum Alley Investments | Daniel Franke, Associate, M Ventures | Ben Freeberg, Senior Associate, Alpha Venture Partners | Kyle Fugere, Head of Ventures, dunnhumby Ventures | Alexander Galitsky, Co-Founder and Managing Partner, Almaz Capital | Anna Garcia, General Partner, Runway Venture Partners | Elaine Gilde, Board Member, New York Angels | Stephen Gilfus, Founder, Blackboard Inc. | Karim Gillani, General Partner, Luge Capital | Alex Goldberg, Managing Director, Canary Ventures | Samara Gordon, Senior Associate, Hyperplane Venture Capital | Edward Greer, Corporate Technology Scout, Dow Ventures | Amanda Groves, Partner, PLUS Capital | John Gu, Investor, Spring Mountain Capital | Whitney Haring-Smith, Managing Partner, Anzu Partners | Will Hawkins, Senior Associate, Founder Collective | Martin Heidecker, Director, Investment Manager, Boehringer Ingelheim Venture Fund | Diane Henry, Founder, Rogue Capital Collective | Cat Hernandez, Partner, Primary Venture Partners | Ann Hickey, Vice President, Town Hall Ventures | Kyle Howard-Johnson, Investor, Catalyst Investors | Vinay Iyengar, Investor, Bessemer Venture Partners | Deborah Jackson, Founder, Plum Alley Investments | Dhruv Jain, Investor, Bessemer Venture Partners | Christina Jenkins, Lead Investor, Portfolia | Del Johnson, Principal, Backstage Capital | Joseph Kao, Principal, Millennium Technology Value Partners | Jay Karandikar, Venture Partner, New Crop Capital | Hana Khosla, Investor, Activant Capital | Avery Klemmer, Investor, FirstMark Capital | Jak Knowles, Vice President Venture Investments, Leaps by Bayer | Steve Konsek, Program Director, National Science Foundation | George Krautzel, Managing Partner, MissionOG | Ricky Lai, Senior Associate, Portag3 Ventures | Eddie Lee, Senior Associate, White Star Capital | Oivind Lorentzen, Investor, Oak HC/FT | Marissa Lowman, Head of Education Practice, Village Capital | Bion Ludwig, Partner, Savano Capital Partners | Coppelia Marincovic, Investment Manager, Solvay Ventures | Elizabeth McCluskey, Principal, Impact Engine | Shripal Meghani, Partner, Cleveland Clinic Ventures | Arpesh Mehta, Investment Director, DSM Venturing | Andrée-Lise Méthot, Founder & Managing Partner, Cycle Capital Management | Ed Michael, Co-founder and Managing Partner, LionBird Ventures | Bá Minuzzi, General Partner, BABEL Ventures | Karolina Mrozkova, Associate, White Star Capital | Sonia Nagar, Partner, Pritzker Group Venture Capital | Greg Neufeld, Partner, ValueStream Ventures | Stuart O’Keeffe, Principal, Great Oaks Venture Capital | Jason Palmer, General Partner, New Markets Venture Partners | Victor Pascucci III, Managing Partner, Lightbank | Matt Perlman, Principal, IA Capital Group | Victoria Pettibone, Managing Director, Astia Angels | Daniel Pianko, Partner, University Ventures | Adam Plotkin, Partner, ff Venture Capital | Jean-Noel Poirier, Managing Partner, Clean Energy Venture Group | Bryan Rabenau, Principal, BP Ventures | Suraj Kumar Rajwani, General Partner, DoubleRock | K.P. Reddy, Founder, Shadow Ventures | Alison Andrews Reyes, General Partner, 1843 Capital | Lisa Rhoads, Managing Director, Easton Capital | Douglas Roth, Managing Director, Connecticut Innovations | Boris Ryabov, Managing Partner, Bright Capital | Ernst Sack, Partner, Blue Bear Capital | Praveen Sahay, Managing Director, WAVE Equity Partners | Zak Schwarzman, Partner, MetaProp | Thomas Seo, Vice President, Citi Ventures | Connie Sheng, Founding Managing Partner, Nautilus Venture Partners | Jaidev Shergill, Managing Partner, Capital One Growth Partners | Zacary Sherman, Associate, Pereg Ventures | Nicole Shimer, Investment Associate, Insight Partners | Bennett Siegel, Investor, Coatue Management | Raj Singh, Managing Partner, JetBlue Technology Ventures | Jean Sini, Angel Investor | Vivek Soni, Venture Partner, S Cap Cleantech Fund | Corinne Spears, Associate, University Ventures | Amit Srivastava, Senior Partner, Cycle Capital Management | Nico Stainfeld, Analyst, Citi Ventures | Lutz Stoeber, Investment Director, Evonik Venture Capital | Neil Swami, Principal, Catalyst Health Ventures | David Sym-Smith, Partner, Mobility Ventures | Nilay Thakar, Associate, ARCH Venture Partners | Chisom Uche, Senior Associate, SixThirty | Erica Van, Associate, Charles River Ventures | Maria Velissaris, Founding Partner, SteelSky Ventures | David Wadler, Vendorful, Co-founder and CEO | Patrick Walsh, Director, National Grid Partners | Jamie M. Weston, Managing Director, Spring Mountain Capital | Tom Wisniewski, Co-Founder & Managing Partner, Newark Venture Partners | Simon Wu, Principal, Cathay Innovation | Anthony Xu, Partner, New Ground Ventures | Lisa Xu, Investor, FirstMark Capital | Wesley Yiu, Senior Associate, Triphammer Ventures | Chris Young, Partner, Revel Partners | Greg Zaic, General Partner, NMT Capital | Katherine Zamsky, Managing Partner, Carbon Ventures | Stephanie Zepeda, Senior Associate, Arbor Ventures | Lu Zhang, Founder & Managing Partner, Fusion Fund | Chris Zock, Managing Director , Sandbox Insurtech Ventures and many more.

 

Special Offer:

Leaders in Pharmaceutical Business Intelligence Group has made special arrangement for our network to

receive $100 off the current rates.

Registration closes July 3rd

This conference will be attended by the best people in the industry. Please register asap to avoid disappointment.

Register Today & Save Click here.   

(Use promo code “LPBIVIP”)

In addition to providing access to leading Investors, the conference will feature more than 100 pre-screened venture backed, emerging and early stage companies seeking capital, and hardcore networking.

 

Call for TOP INNOVATORS!

Get Noticed > Get Funded > Grow Faster

 

A select group of more than 100 Top Innovators from the Technology, Life Sciences/Healthcare, CleanTech and Fintech sectors will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners.

 

Apply to Present / Nominate a company:

For more information or to be considered for one of the Top Innovator slots click here.

 

Seed Pitchfest:

If you are a seed stage company seeking angel funding of less than $1M (and have raised less than $300,000) click here to apply for our Seed stage track.

We look forward to seeing you there.

Leaders in Pharmaceutical Business Intelligence Group

&

youngStartup Ventures

 

Read Full Post »


Real Time Coverage @BIOConvention #BIO2019: June 4 Morning Sessions; Global Biotech Investment & Public-Private Partnerships

Reporter: Stephen J Williams PhD @StephenJWillia2

Each country have their own needs and most important drug cost structure. Must involve patients and providers.
BCI survey: countries output different, who improved who didnt
Is industry having collaboration with government? hardly ten percent by survey and worse vice versa
Transparancy and holistic view important for collaboration
Korea: lack of communication need input from government on pricing; wants global open innovation and enhance RD investments
Tawain: price, price but based on efficacy; pharma needs to talk with doctors hospital patients, find balance
Pitts: we need trust; staff that country offices with people who know that country. Price not defining value
Columbia:  need to attract investors

Please follow LIVE on TWITTER using the following @ handles and # hashtags:

@Handles

@pharma_BI

@AVIVA1950

@BIOConvention

# Hashtags

#BIO2019 (official meeting hashtag)

Read Full Post »

Older Posts »